




Dissertation Title: The Role of Adipocyte Lipid Droplet Lipolysis in 
Thermogenesis and Metabolic Health 
  
 Hyunsu Shin, Doctor of Philosophy, 2017 
  
Dissertation directed by: Liqing Yu,  
Associate Professor 
Department of Animal and Avian Sciences 
University of Maryland at College Park 
Professor 
Center for Molecular and Translational Medicine 
Institute for Biomedical Sciences 








My thesis was focused on the role of Comparative Gene Identification-58 (CGI-
58)-mediated adipocyte lipid droplet (LD) lipolysis in thermogenesis and metabolic 
health. LD lipolysis in energy-dissipating brown adipose tissue (BAT) was believed 
to play a central role in cold-induced non-shivering thermogenesis, but this concept 
has not been tested in whole animal in vivo. We created a mouse line that lacks 
BAT CGI-58, a coactivator of Adipose Triglyceride Lipase (ATGL) that initiates the 
first step of cytosolic LD lipolysis by cleaving a fatty acyl chain from a triglyceride 
(TG) molecule. We found that BAT-specific CGI-58 knockout (BAT-KO) mice 
defend against the cold normally when food is absent, despite a defect in BAT LD 
lipolysis. Interestingly, BAT-KO versus control mice display higher body 
temperature when food is present during cold exposure. This cold adaptation in 
BAT-KO mice is associated with increases in BAT glucose uptake, insulin 
sensitivity, white adipose tissue (WAT) browning, energy expenditure, and 
sympathetic innervation. To identify the sources of fuels for thermogenesis of BAT-
KO mice in the fasted state, we hypothesized that WAT lipolysis is a major source 
of thermogenic fuels during fasting. To test this hypothesis, we genetically 
inactivated CGI-58 expression in the whole fat tissues (both BAT and WAT) of 
mice (FAT-KO mice). We observed that FAT-KO mice are cold sensitive when food 
is absent, but tolerate cold normally when food is present, demonstrating that WAT 
lipolysis is essential for cold-induced thermogenesis during fasting and that dietary 
nutrients can substitute WAT lipolysis for fueling whole-body thermogenesis. 
Intriguingly, FAT-KO mice display a dramatic increase in cardiac glucose uptake 
under both basal and insulin-stimulated conditions, which is associated with 
significant increases in glucose tolerance, insulin sensitivity, and cardiac 
expression levels of natriuretic peptides. In conclusion, our studies demonstrate 
that 1) BAT LD lipolysis is not essential for cold-induced whole-body 
thermogenesis due to increased BAT uptake of circulating fuels and WAT 
browning; 2) WAT lipolysis is required for fueling thermogenesis during fasting; 
and 3) Adipose lipolysis is critically implicated in whole-body energy metabolism 
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Figure 1. Hematoxylin and Eosin (H&E) staining of WAT and BAT. WAT 
contains a unilocular lipid droplet (LD) in a cell (left), whereas BAT contains 
multilocular LDs in a cell (right). 
INTRODUCTION 
 
Body temperature maintenance is critical for survival of animals and humans. 
During cold exposure, heat is produced mainly through shivering thermogenesis 
and non-shivering thermogenesis (NST). Shivering thermogenesis is the rapid 
heat production through skeletal muscle shivering, which is a mechanism against 
acute cold exposure. NST is an adaptive mechanism against chronic cold 
exposure, which occurs in brown adipocytes present in specific fat depots. Due 
to the role of NST in energy dissipation, there has been growing interest in 
studying NST regulation and its impact on obesity and associated metabolic 
disorders.  
Fat tissues can be broadly divided into two major types: white adipose 
tissue (WAT) and brown adipose tissue (BAT), each has distinct morphology 
(Figure 1). WAT stores energy as a single large lipid droplet (LD) in each 
adipocyte and mobilizes it during increased energy demand or fasting. BAT 
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contains brown adipocytes, each of which is filled with multiple small LDs and 
dissipates energy as heat through NST during cold adaption [1-11]. Since the 
1970s, BAT has been recognized as the main non-shivering thermogenic organ, 
which was initially thought to be relevant only to rodents, hibernating mammals, 
and newborn humans [1-3, 5]. However, positron emission tomography (PET) 
and 18fluorodeoxyglucose uptake studies have recently revealed that adult 
humans have dispersed BAT [12-16], which has revitalized interest in basic and 
clinical research of BAT biology. A major function of BAT is to defend against the 
cold in a nonshivering manner by generating heat using fatty acids, glucose and 
other chemicals [2, 17-19]. Uncoupling protein-1 (UCP-1) plays an essential role 
in this process because it uncouples mitochondrial oxidation of substrates from 
ATP synthesis [2].  
In addition to white and brown adipocytes, a third type of adipocyte has 
been discovered in humans and rodents [3, 20, 21]. These cells appear in WAT 
depots and have a different developmental origin from brown adipocytes [22, 23]. 
They attain brown adipocyte features under β-adrenergic or cold stimulation and 
are called the brown-like (beige) or brown-in-white (brite) adipocytes [24-30]. 
Although the thermogenic capacity of beige/brite cells is lower than that of 
classical brown adipocytes, beige/brite cells have been shown to be thermogenic 
[17, 28, 29]. Recruitment of these beige adipocytes to WAT is called WAT 
Browning. It was shown that the presence of BAT or beige adipocytes is 
negatively correlated with obesity in humans and rodents [31]. Therefore, 
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inducing beige or brown adipocytes in humans may have a therapeutic potential 
for treating obesity and associated metabolic diseases.  
I. Origins of Brown/Beige Adipocytes 
NST is solely dependent on brown adipocytes. However, under prolonged cold 
stimulation, beige adipocytes are recruited to meet increased demand for heat. 
While classical brown adipocytes are reportedly derived from engrailed-1-
expressing cells in the central dermomyotome [32] and a Myf5-positive lineage 
[24], the origins of beige/brite adipocytes in the browned WAT are under hot 
debate [33-35]. Some studies showed that they can arise de novo from 
precursor cells [27, 28, 36-41], but others showed that they can originate from 
“transdifferentiation” of existing white adipocytes [25, 34, 42-50] that are likely 
derived from the progenitors residing in the adipose vasculature [51], or 
sometimes from Myf5+ lineage [24, 52], or both [53, 54]. These observations may 
imply that beige adipocytes likely have multiple cellular origins, depending on 
pathological conditions, and are composed of heterogeneous cell populations.  
 
II. Regulation of Brown/Beige Adipocyte Thermogenesis 
1. Transcriptional Regulators 
Transcriptional factors involved in the thermogenic programming during 
brown/beige cell recruitment are described in Figure 2 [55].   
1) Peroxisome Proliferator-Activated Receptors (PPARs) and CCAT-
Enhancer-Binding Protein-beta (C/EBP-β)  
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Figure 2. Transcriptional and Hormonal Regulation of the Thermogenic 
Program.  
Activation of themogenic brown adipocytes (top) and beige adipocytes in 
white adipocytes (bottom). Endocrinologic factors, such as Neuronal factors, 
norepinephrine; cardiac factors, natriuretic peptides (NPs); liver and brown 
adipose tissue (BAT) factors, fibroblast growth factor (FGF)21; thyroid 
factors, thyroxine (T3); bone morphogenic proteins (BMPs) and muscle 
factors, irisin. Adapted from Harms and Seale, 2013 [55]. 
 
Among three members of the PPARs family, PPAR-γ is specific for adipogenesis 
by promoting differentiation of pre-adipocytes into mature adipocytes [56]. 
Besides PPAR-γ, C/EBPs also regulates the differentiation program in the 
adipose lineage [57]. These two factors not only control white adipose tissue 
homeostasis, but also the development of brown and beige adipocytes. For 
example, C/EBP-β expression in BAT is higher than that in WAT [58]. White 
adipocyte C/EBP-β induces the brown fat transcriptional pattern. C/EBP-β null 
mice fail to generate heat and their UCP1 mRNA and protein levels in BAT are 
lower than those of control mice [58]. A recent study showed that high-fat diet 
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(HFD)-induced expression of PPAR-γ is associated with vagal neuronal 
innervation and subsequently stimulates beige cell programing in inguinal 
subcutaneous fat (iWAT) [59]. Mice with a PPAR-γ dominant-negative mutation 
show cold intolerance and reduced expression of UCP1 in BAT and WAT [60]. 
PPAR-γ, as an adipocyte development-associated gene, is essential for 
adipocytes to undergo thermogenic differentiation. Many studies have shown that 
precursor cells in WAT can express UCP1 mRNA and develop a beige fate in 
response to PPAR-γ agonist treatment [61]. It is well known that 
thiazolidinediones, as PPAR-γ agonists, trigger thermogenic program in BAT and 
WAT by activating genes involved in UCP1 activation and mitochondrial 
biogenesis [26, 61]. The thermogenic effect of PPAR-γ agonists is mediated by 
direct activation of thermogenic genes via the PPAR response element in their 
promoters and enhancers [62, 63], and some of these genes are involved in 
provision of thermogenic fuels by increasing BAT uptake of free fatty acids (FFA 
s) [64]. In contrast to many observations in which PPAR-γ induces the 
brown/beige phenotypes, TLE3 competes with PR (PRD1-BF1-RIZ1 
homologous)-domain-containing protein 16 (PRDM16) for binding sites in PPAR-
γ, which allows PPAR-γ to repress brown/beige cell recruitment while inducing 
white adipocyte recruitment. [65]. In addition to PPAR-γ, PPAR-α is implicated in 
thermogenic program by stimulating mitochondrial respiration and β oxidation of 
FFAs [66].  
2) PRDM16  
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PRDM16 was initially identified at a chromosome breakpoint in myeloid leukemia 
[67]. A later study found that PRDM16 controls brown fat/skeletal muscle switch 
[24]. When PRDM16-expressing fibroblasts are implanted subcutaneously into 
nude mice, the fat pads derived from PRDM16-expressing cells relative to the 
controls show at least a five-fold increase in expression levels of brown fat 
selective genes, such as UCP1, Cidea, PPAR-γ coactivator 1-α (PGC1-α), and 
PPAR-α [24]. Furthermore, PRDM16 is sufficient to induce browning of 
subcutaneous fat [26]. When the PRDM16 DNA binding domain is mutated, the 
brown fat phenotype is no longer present, suggesting that it may function as a 
transcriptional co-regulator [24]. A subsequent investigation determined that 
PRDM16 acts through binding and co-activating PGC-1β, PGC-1α, and PPAR-γ 
[68]. PRDM16 can form a transcriptional complex with the active form of C/EBP-β 
[26]. As mentioned above, C/EBP-β is required for initiating the myoblast-to-BAT 
conversion [57, 58]. Co-transplantation studies with myoblasts expressing 
PRDM16 and C/EBP-β suggest that C/EBP-β mediates the myoblast-to-BAT 
conversion in a PRDM16-dependent manner [58]. In addition, PRDM16 has been 
shown to be  a key factor for full functioning of PPAR-γ in response to the PPAR-
γ agonist rosiglitazone [61]. Transgenic expression of PRDM16 in adipose 
tissues of mice increases expression levels of UCP1 and other browning-related 
genes in iWAT in response to rosiglitazone [26]. Several factors have been 
reported to regulate Whitening or Browning differentiation by modulating 
PRDM16 [24, 26]. The iWAT in adipose tissue-specific PRDM16 knockout (KO) 
mice induced by adiponectin-cre expression display visceral white adipose tissue 
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(vWAT)-like features [69], suggesting an epistatic relationship between a 
PRDM16 thermogenic program and a WT1 visceral program (WT1 is one of the 
visceral signature genes including WT1, TCF21, and BNC1) [69]. Interestingly, 
miR-133, a muscle specific microRNA, can directly antagonize PRDM16 [70-73]. 
It was shown that cold represses miR-133 expression in fat cells and 
subsequently induces PRDM16 expression, which increases expression of its 
downstream thermogenesis-associated genes [72].  
3) PGC1-α 
PGC1-α is considered as a master regulator of mitochondrial biogenesis. As a 
transcription factor closely associated with oxidative metabolism, it is involved in 
regulation of nuclear receptors, estrogen-related receptors, and FoxO 
transcription factors in multiple tissues [74-78]. Especially, PGC1-α expression in 
adipocytes is strongly correlated with UCP1 expression as well as other 
thermogenic components [76, 79]. Mechanistically, there is a robust activation of 
the sympathetic nervous system (SNS) stimulation under the cold condition. 
Upon SNS stimulation, β-adrenoceptor triggers cAMP and activates protein 
kinase A (PKA) that phosphorylates lipolytic-associated enzymes and p38 
mitogene activated protein kinase (MAPK). MAPK is essential for cAMP-
dependent transcription of PGC1-α in BAT. A previous study showed that p38 
MAPK is required for a β-adrenergic agonist to induce PGC1-α mRNA 
expression [80, 81]. Furthermore, the nuclear co-repressor Rip140 recruited by 
liver X receptor-α to the DR-4 element in the UCP1 enhancer adjacent to 
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PPAR/Retinoid X receptor binding DR-1 domain represses PGC1-α, which leads 
suppression of UCP1 expression [82, 83].  
4) Sirtuin 1 (SirT1) 
SirT1 is a member of the sirtuin protein family and is characterized by a sirtuin 
core domain grouped into four classes. SirT1 is involved in glucose metabolism 
and insulin secretion by repressing protein tyrosine phosphatase activity [84]. 
SirT1-associated protection against metabolic damages occurs via stimulating 
PGC1-α and lowering proinflammatory inactivation by cytokines, such as tumor 
necrosis factor-α and interluekin-6 [85]. The specific mechanism for SirT1 to 
regulate the thermogenic program was recently identified. SirT1 serves as an 
NAD-dependent protein deacetylase linking transcriptional regulation to 
intracellular energetics and mitochondrial oxidation. SirT1 specifically regulates 
PPAR-γ activity by deacetylating PPAR-γ Lys268 and Lys293 sites. A 
deacetylated PPAR-γ mutant in 3T3-L1 cells promotes lipid accumulation, 
increases expression of the insulin sensitizing adipokine, adiponectin, and 
induces degradation of anti-adipogenic β-catenin, indicating that deacetylation of 
PPAR-γ is required for its full activity. SirT1-dependent deacetylation of Lys293 
and Lys268 on PPAR-γ is required to recruit PRDM16 to PPAR-γ [71]. 
Additionally, dietary supplementation of a SirT1 activator, resveratrol, results in 
higher energy expenditure and lower fat accumulation in mice [86].  
  
2. Endocrine, Paracrine, and Autocrine Factors 
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Some endocrine, paracrine, and autocrine factors produced by brown adipocytes 
and other cells can promote brown/beige adipocyte thermogenesis, such as 
fibroblast growth factor 21 (FGF21) from liver, thyroid hormone from thyroid 
gland, natriuretic peptides (NPs) from heart, and bone morphogenetic proteins 
(BMPs) from brown adipocytes (Figure 2). 
1) FGF21 
FGF21 is a polypeptide growth factor that is mainly expressed in liver and acts as 
a hormone on adipose tissue, skeletal muscle [87, 88] and other tissues. The 
effect of FGF21 on adipocytes is controversial. Although FGF21 activity is known 
to enhance energy expenditure and mitochondrial biogenesis, the role of FGF21 
treatment in intracellular lipolysis is somewhat controversial [89-92]. Some 
studies have shown induction of adipose triglyceride lipase (ATGL) in adipocytes 
[93], whereas other studies showed reduced ATGL expression and circulating 
FFA level after administrating FGF21 [90]. More recently, the suppressive effect 
of FGF21 on growth hormone-induced lipolysis in adipocytes has been reported 
[94]. However, considering that energy expenditure and mitochondrial activity are 
heavily dependent on oxidation of FFAs, products of lipolysis, FGF21 seems to 
be positively correlated with lipolysis. Signaling to release hepatic FGF21 
involves increased FFAs, which act as ligands for PPAR-α. Activated PPAR-α 
increases FGF21 expression during fasting [95]. FGF21 treatment increases 
phosphorylation of AMPK in 3T3-L1 cells, stimulating SirT1 through modulation 
of intracellular NAD+/NADH levels. When SirT1 is knocked-down by shRNA in 
vitro, FGF21 cannot further deacetylate PGC1-α, which results in inactivation of 
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the thermogenic program [96]. The effect of FGF21 on mitochondrial energy 
expenditure is likely mediated by serine/threonine kinase 11 that activates AMPK 
activity to induce SirT1, causing deacetylation of PGC1-α [96]. 
Hormonal regulation of FGF21 has been reported. FGF21 interacts with β-
klotho, an FGF21 signaling cofactor that is ubiquitously expressed. The 
FGF21/β-klotho interaction in hypothalamus stimulates energy expenditure and 
browning of iWAT by enhancing the SNS activity [93]. Although the main source 
of FGF21 is the liver, other organs, such as muscle and adipose tissues, produce 
FGF21 under some circumstances. When the autophagy pathway is inhibited in 
mice by genetically deleting autophagy related 7, skeletal muscle releases 
FGF21 as a myokine for recruitment of beige cells to compensate for failure of 
autophagy-dependent energy degradation in skeletal muscle [97]. These mice 
have a lean phenotype and less adipose hypertrophy. FGF21 has a beneficial 
insulin-sensitizing effect by regulating insulin action [98]. However, high 
circulating FGF21 levels in humans are correlated with the occurrence of 
metabolic diseases, including type 2 diabetes and non-alcoholic fatty liver 
disease [99], suggesting FGF21 resistance or metabolic stress when 
administered at a supraphysiological dose. Further studies are needed to 
examine the mechanisms underlying FGF21 resistance or metabolic stress 
associated with high doses of FGF21 before its clinical use in metabolic diseases 
and thermoregulation. 
2) Thyroid Hormone  
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Thyroid hormone reduces the proton motive force by facilitating the leak of 
protons through the inner mitochondrial membrane (IMM). Hafner et al. showed 
that hyperthyroidism is correlated with increased respiration, without ATP 
turnover, suggesting that thyroid hormone-induced energy expenditure may 
occur via mitochondrial uncoupling [100]. This implication is consistent with that 
Na+-K+-ATPase in liver membranes increases in a thyrotoxic state [101]. In BAT, 
cold adaptation increases type II iodothyronine 5’ deiodinase (Dio2), which 
converts thyroxine (T4) to triiodothyronine (T3), the active form of thyroid 
hormone, to activate the thermogenic program T3 [102, 103]. UCP1 levels in 
response to SNS stimulation are modest without thyroid hormone, whereas the 
expression levels of UCP1 are 18-20-fold higher after SNS activation than the 
basal condition in the presence of thyroid hormone, specifically T3 [102]. In 
agreement, hypothyroidism reduces the number of β-adrenergic receptors [104] 
and the induction of Giα or Gbγ protein subunits in WAT [105, 106]. Although 
Dio2, UCP1, and PGC1-α mRNA levels are normal, thyroid hormone receptor 
(TR)-α KO mice fails to adapt to cold [107].  
3) Natriuretic Peptides (NPs) 
The cardiac NPs, atrial NP (ANP) and brain NP (BNP), are cardiometabolic 
hormones released from the heart and regulate hemodynamic homeostasis. 
Plasma ANP and BNP increase with severity of heart failure [108]. They promote 
natriuresis (sodium excretion in the urine) through vasodilation by inhibiting the 
renin-angiotensin-aldosterone system. The role of NPs in regulating 
thermogenesis via a catecholamine-independent mechanism was recently 
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identified [109]. There are two NP receptors. NP receptor A (NPRA) binds 
ANP/BNP and this binding increases cyclic guanosine monophosphate (cGMP). 
Increased cGMP activates the α- and β- subunits of protein kinase G (PKG) to 
phosphorylate p38 MAPK. The activated p38 MAPK subsequently 
phosphorylates the transcriptional regulator PGC1-α and further activates 
transcription factors for the UCP1 enhancer, PPRE, and CRE2 [109]. It was 
shown that ANP binding to NPRA induces UCP1 expression and respiration in 
human multipotent adipose-derived stem cells [109]. Similar to catecholamine 
effects, activation of NP signaling also induces phosphorylation of hormone 
sensitive lipase (HSL)- and perilipin 1 (Plin1) to promote cytosolic LD lipolysis in 
adipocytes [110, 111]. In addition, ANP and BNP upregulate mitochondrial genes 
associated with FFA oxidation and mitochondrial biogenesis in adipocytes via 
NPRA [112]. Compared with NARA, NP receptor C (NPRC) has an opposite 
effect on NPs. It mediates degradation of ANP/BNP and therefore clearance of 
NPs from the circulation. 
4) Bone morphogenetic proteins (BMPs) 
BMPs are growth factors implicated in the regulation of tissue architecture. 
Various BMP family members recruit precursor cells into the adipocyte lineage. 
BMP2 and 4 are involved in white adipogenesis [113, 114], whereas BMP7 is 
related to brown adipogenesis [115]. Some studies have reported that BMP4, 7, 
and 8B promote beige adipocyte recruitment [116, 117]. The BMP8B level 
increases in mature BAT in response to increased catecholamines, which 
activates p38 MAPK/CREB signaling and increases lipase activity. BMP8B KO 
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mice display reduced metabolic rates and impaired thermogenesis [117]. Mice 
lacking the type 1A BMP receptor in brown adipocyte progenitor cells exhibit a 
severe paucity of interscapular brown adipose tissue (iBAT), which in turn, 
increases sympathetic innervation into iWAT to induce beige cell recruitment 
[118].   
In addition to autocrine functions of BMPs in BAT, BMP8B may have a central 
role for modulating BAT thermogenesis by activating the AMPK-orexin (OX) axis 
[119]. Hunger regulation is modulated by the lateral hypothalamic area (LHA). 
Satiety is regulated in the ventromedial nucleus of the hypothalamus (VMH). 
Suppression of AMPK in the VMH [120, 121] or stimulation of orexigenic tone in 
the LHA activates the brown/beige thermogenic program. BAT development and 
differentiation require OX neurons in the LHA [122, 123]. In a recent study, a 
significant elevation in body temperature was observed in mice after treatment 
with BMP8B within the VMH [119]. These studies suggest a central role of 
BMP8B in regulating thermogenesis via influencing the VMH-LHA interplay.   
5) Vasculature factors 
Nitric oxide (NO) is synthesized in endothelial cells and promotes BAT 
mitochondrial respiration and biogenesis [124]. Soluble guanylyl cyclases are 
activated by NO, increase cGMP, and subsequently stimulate PKG activity to 
promote brown/beige recruitment and UCP1 expression [125-127].  
Overexpression of vascular endothelial growth factor (VEGF) A increases 
vascularization and upregulates UCP1 and downstream brown markers [128]. 
Similarly, deletion of VEGF receptor 2, one of two tyrosine kinase receptors for 
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Figure 3. Proposed Model of Thermogenic Regulation in Brown/Beige 
Adipocytes. Norepinephrine stimulates a signaling cascade that activates 
intracellular lipolysis of lipid droplets (LDs). FFAs that are released either 
directly bind to UCP1 or undergoes β-oxidation. The Generated proton 
gradient is subsequently utilized via UCP1 to generate heat. ETC, Electron 
transport chain; TCA, Tricarboxylic acid cycle; βox, β-oxidation. Adapted 
from Cannon and Nedergaard, 2004 [2]. 
 
VEGF, in mice results in impaired beige recruitment [129]. Both NO and VEGF 
seem to use a paracrine mechanism in endothelial cells for control of the brown 
adipocyte phenotype. 
III. The Role of FFA in Thermogenesis 
FFAs are essential for mitochondrial respiration, β-oxidation, and activation of 
UCP1 in mitochondria (Figure 3) [2]. First, FADH2, NADH, and acetyl-coA are 
generated via β-oxidation of FFAs in the mitochondria. These products are 
further utilized in the electron transport chain (ETC). The ETC or so-called, 
mitochondrial respiratory chain, consists of five complexes. Complexes I, III, and 
IV pump protons out of the inner membrane by oxidizing NADH and FADH2 to 
NAD+ and FAD+. The proton gradient generated by ETC is subsequently 
coupled to generate ATP by complex V, an ATP synthase. However, protons in 
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brown adipocytes are dissipated as heat via UCP1 that increases the 
permeability of the inner membrane causing protons returned to the 
mitochondrial matrix from the intermembrane space of mitochondria. In addition 
to mitochondrial β-oxidation for the uncoupling process, FFAs are required for 
activation of UCP1 [130-132]. UCP1 shares its tripartite structure and amino acid 
sequence with other family members, including UCP2 and UCP3. The binding 
domains of purine nucleotides, such as GDP, ADP, or ATP are conserved among 
UCP members. However, UCP1 is specific in that it has a central loop facing the 
matrix and its last part of the COOH terminus faces the cytosol [2, 133].These 
unique sequences and topology of UCP1 may contribute to its thermogenic 
function. Some studies have examined potential molecular mechanisms 
underlying FFA-mediated UCP1 activation. It has been shown that GDP inhibits 
proton permeability [130] and that the FFA derivatives acyl-CoAs compete with 
bound purine nucleotides [134]. Other studies also examine the role of FFAs in 
activating UCP1 [135, 136]. The current working models of how FFAs increase 
UCP1 activity include: an H+ channel is activated by allosteric binding of FFAs 
[137, 138]; an OH- channel is activated by allosteric binding of FFAs [132]; and 
the FFA cycling model. In the FFA cycling model, UCP1 catalyzes translocation 
of FFAs in anionic form, and the carboxylic group picks up a proton from the 
cytosolic side, so that the protonated FFAs flip-flop to the matrix side [139]. 
Although the molecular detail for UCP1 activation by FFAs remains elusive, it is 
commonly accepted that UCP1 activity depends on allosteric binding of long 
chain fatty acids (LCFAs) [132, 137, 139, 140]. Thus, FFA flow into mitochondria 
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Figure 4. Intracellular Lipolysis. Under the basal condition, lipolytic enzymes 
adipose triglyceride lipase (ATGL), hormone-sensitive lipase (HSL) and 
monacylglycerol lipase (MGL) are not associated with lipid droplets (LDs). LDs 
are shielded by perilipin and its associated comparative gene identification-58 
(CGI-58), a coactivator of ATGL. Under the stimulated condition, perilipin is 
phosphorylated, releasing CGI-58 to recruit ATGL onto LDs, which together 
with translocation of phosphorylated HSL initiates the lipolytic cascade. 
Adapted from [11]. 
 
is indispensable for generating a proton gradient via β-oxidation and for binding 
and activating UCP1. 
  
IV. Intracellular Lipolysis and Thermogenesis 
Excess energy is stored as TG-rich LDs in the cytosol of adipocytes. During 
starvation or increased energy demand, this stored energy is mobilized via a 
process called intracellular lipolysis (Figure 4) [11].  
 Intracellular lipolysis is regulated by hormones and coordinated by many 
LD coat proteins and lipases [11, 141, 142]. ATGL is a cytosolic neutral lipase 
that initiates “Cytosolic/Neutral” Lipolysis by cleaving a fatty acyl chain from a 
triglyceride (TG) molecule [11, 143-146]. CGI-58 [147], also known as Abhd5, is 
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the fifth member of /-hydrolase fold protein family [148-150]. It is ubiquitously 
expressed with the highest expression in adipose tissues [151-155]. CGI-58 
binds to cytosolic LDs via interactions with members of the PAT family [151, 153, 
156-162]. It is the causative gene for Chanarin-Dorfman syndrome, a neutral-lipid 
storage disease [163, 164] associated with ichthyosis (scaly dry skin) and 
cytosolic accumulation of TG-rich LDs in most cell types. Purified CGI-58 
promotes ATGL’s activity in vitro by acting as a coactivator [152], though it clearly 
has ATGL-independent lipolytic functions [150, 152, 153, 158, 159, 165-169]. 
Since it is well established that CGI-58 limits LD deposition by promoting TG 
hydrolysis, not by inhibiting TG synthesis, CGI-58 may also activates other 
intracellular lipolytic pathways, one of which is the lipid-specific macroautophagy 
(lipophagy) that clears cytosolic LDs by delivering LD to lysosomes for 
degradation by lysosomal acidic lipase (“Lysosoma/Acidic” Lipolysis) [170]. 
 Lipolysis in adipocytes is often triggered by catecholamine stimulation of 
Gαs-coupled β-adrenergic receptors, which activates adenylyl cyclase to raise 
intracellular cAMP levels, leading to activation of PKA. Activated PKA 
phosphorylates HSL and Plin1. Under the basal condition, CGI-58 is bound to 
LDs by interacting with Plin1. This association may prevent ATGL from gaining 
access to LDs. Phosphorylation of Plin1 by PKA results in release of CGI-58 that 
subsequently recruits ATGL onto LDs to initiate TG hydrolysis. One study 
reported that CGI-58 Ser239 is also phosphorylated by PKA after lipolytic 
stimulation, which contributes to dispersion of CGI-58 from LDs and increases 
the co-activator function of CGI-58 [171].  
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Some lipolytic regulators or enzymes are implicated in thermoregulation. 
For example, the transcription regulator SERTA domain containing 2 (SERTA2, 
also known as TRIP-Br2) is involved in fat lipolysis, energy metabolism and 
thermogenesis [172-174]. TRIP-Br2 knockout mice are lean and show increased 
lipolytic activity. The increased lipolysis is HSL-dependent, whereas ATGL and 
CGI-58 activities remain normal in these animals [172].Ablation of TRIP-Br2 
promotes transcription of β3-adrenergic receptors, energy expenditure, and FFA 
oxidation, which increases thermogenesis [172]. Mammalian target of rapamycin 
(mTOR) is a master regulator of many important metabolic processes, including 
energy expenditure, autophagy, protein synthesis, and lipogenesis [175, 176]. 
Inhibition of the mTORC1 signaling pathway in vitro promotes TG lipolysis to 
release FFAs [177]. Mice lacking raptor, a key component of mTOR complex 1 
(mTORC1), display enhanced expression of UCP1, suggesting that mTORC1 
may suppress thermogenesis [178]. The growth factor receptor-binding protein-
10 (Grb10) was originally identified as a negative regulator of insulin and insulin-
like growth factor-1 signaling pathways [179, 180]. A recent study identified Src 
homology 2 domain containing protein Grb10 as a direct substrate of mTORC1 
[181, 182]. Liu et al. generated adipose-specific Grb10 knockout mice to study 
the role of Grb10 in adipocytes and found that these mice display reduced ATGL 
phosphorylation and total HSL protein, which is associated with increased fat 
mass [183]. G0/G1 switch gene 2 (G0S2), a negative regulator of cytosolic 
lipolysis [184], is also involved in thermogenesis in adipocytes [185]. Zandbergen 
et al. reported that G0S2 mRNA levels in adipose tissue are upregulated during 
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adipogenic differentiation [186]. G0S2 attenuates ATGL action both in vivo and in 
vitro [187]. Mice lacking G0S2 are lean due to increased ATGL-dependent 
lipolytic activity and they are cold tolerant [185, 188]. 
In addition to lipolysis regulators, lipolytic enzymes can also affect 
thermoregulation. Adipose-specific ATGL knockout mice show increased 
expression of WAT-enriched genes and decreased expression of BAT-
associated genes in BAT [189]. Systemic deletion of ATGL impairs cold-
tolerance in mice [190]. Controversy exists for HSL. HSL-null mice display 
increased energy expenditure, decreased insulin sensitivity, and increased 
uncoupling activity during cold adaptation [191]. In contrast, TRIP-Br2 KO mice 
show enhanced cold tolerance as a result of upregulated HSL [172]. Overall, the 
tissue-specific role of intracellular lipolysis on thermoregulation remains largely 
unknown. 
2) Intravascular Lipolysis and Thermogenesis  
Intravascular lipolysis is mainly referred to lipoprotein lipase (LPL)-mediated 
lipolysis occurring intravascularly, which releases FFAs from lipoprotein-TG 
particles for tissue uptake (Figure 5). It has been reported that LPL activity 
increases in BAT after a meal [192], when circulating chylomicrons are elevated. 
Cold-activated BAT is an important organ for the uptake of triglyceride-rich 
lipoproteins (TRLs) including chylomicrons and very low density lipoproteins 
(VLDLs), likely by increasing the endothelial permeability. It seems that both FFA 
uptake and TRL internalization into BAT are regulated by LPL activity. When LPL 
activity is inhibited by injecting the specific inhibitor tetrahydrolipstatin, the local 
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Figure 5. Schematic of Intravascular Lipolysis. Adapted from [11]. 
 
BAT FFA and TRL uptake is abolished [192]. Glycosylphosphatidylinositol-
anchored high-density lipoprotein binding protein 1 (GPIHBP1) is responsible for 
anchoring LPL onto capillaries. GPIHBP1 KO mice show mislocalized LPL in 
various tissues including BAT, which decreases tissue TG content and limits 
lipolysis [193]. Following intravascular hydrolysis of TRLs, the released FFAs are 
transported into cells by various transporters. It has been shown that fatty acid 
transporter protein1 (FATP1) increases during brown adipocyte differentiation 
and facilitates FFA uptake in response to adrenergic stimulation [194]. FATP1 is 
highly expressed in adipose tissue and muscle [195]. It is involved in very long 
chain fatty acid (VLCFA) uptake [196, 197]. The muscle in FATP1 null mice has 
reduced FFA uptake in response to insulin stimulation [198]. Interestingly, FAPT1 
knockout mice have impaired heat generation and reduced energy expenditure 
[199]. Cluster-of-differentiation 36 (CD36) is another fatty acid transporter [200-
205]. Similar to glucose transporter (Glut) 4, upon the stimulation of insulin, 
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intracellular cytoplasmic CD36 is translocated to the extracellular side of the 
plasma membrane [206, 207].  Like FATP1 knockout mice, CD36 knockout mice 
show increased plasma FFA concentrations during cold exposure and impaired 
cold tolerance [192]. In particular, CD36 knockout mice display impaired 
thermogenic capacity under the conditions of fasting and cold stress, and they 
are cold sensitive when food is absent during cold exposure [208]. Taken 
together, intravascular lipolysis seems to play an important role in BAT 
thermogenesis.  
 
V. Glucose Uptake and Thermogenesis 
The existence of brown fat-like depots in humans was established by PET-CT 
using a glucose tracer whose uptake is substantially increased in individuals 
exposed to cold [12-16]. Glucose uptake in brown adipocytes upon 
catecholamine stimulation  is more dependent on Glut1 activity than on insulin-
dependent Glut4 activity [209]. One report suggested that Glut1 translocation in 
BAT is mTORC2-dependent [210]. However, FGF21 interplays with insulin to 
regulate glucose uptake [211]. It has been shown that there is a 110-fold 
increase in glucose uptake in BAT under the cold [212]. Deletion of insulin 
receptor in BAT causes reduced BAT mass and FFA synthesis, suggesting the 
importance of insulin action in BAT fat accumulation [213]. Collectively, it seems 
that both Glut1 and Glut4 in BAT may be implicated in cold adaptation.  
During cold adaptation, glucose tolerance is improved and Glut1/Glut4 
mRNA levels are increased, implying that activation of BAT thermogenesis may 
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promote glucose disposal [214]. Mice lacking lipocalin prostaglandin D synthase 
(L-PGDS) show elevated glucose uptake in BAT and increased reliance on 
carbohydrate as a fuel for thermogenesis [215]. It is currently unknown whether 
glucose is directly utilized in brown/beige adipocytes for UCP1-dependent 
thermogenesis or is first converted to fatty acids via de novo lipogenesis and 
then used for heat production. However, it is clear that brown/beige adipocytes 
are major organs for clearing glucose under cold conditions. 
 
VI. Challenges and Hypotheses 
Despite some studies linking ATGL and HSL to thermogenesis, it is currently 
unknown if CGI-58-medaited adipose lipolysis regulates cold-induced 
thermogenesis. Although brown adipocyte LD lipolysis was predicted to be 
central for thermoregulation [2], this prediction has not been tested directly in 
vivo, due to lack of appropriate animal models. It was known that multiple 
substrates can be used for BAT thermogenesis, but several outstanding 
questions exist about regulation of thermogenic substrates selection by BAT. For 
example, how do multiple substrates or different origins of the same substrates 
(e.g., fatty acids from blood versus those from cytosolic LDs) communicate with 
each other in brown adipocytes for thermogenesis? Does intracellular LD 
lipolysis, a cellular process robustly regulated by nutritional, hormonal and 
neuronal signals, play any roles in regulating selection of thermogenic substrates 
or their origins by brown adipocytes? If it does, what is the 
thermogenic/energetic/metabolic consequences when inhibited? Intracellular LD 
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lipolysis is just one (perhaps not a quantitatively critical one) of multiple 
thermogenic substrate sources upstream of the mitochondrial thermogenic 
machinery.  
 The major goal of this project was to establish the role of BAT and WAT 
lipolysis in cold-induced thermogenesis in vivo and in metabolic health using 
BAT-specific CGI-58 knockout (BAT-KO) mice and whole fat CGI-58 knockout 
(FAT-KO) mice. We mainly tested two hypotheses: 1) BAT lipolysis is required 
for cold-induced thermogenesis; and 2) WAT lipolysis is critical in cold-induced 
thermogenesis during fasting. 
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MATERIALS and METHODS 
Materials 
Tris hydroxymethyl amino methane (Tris), sodium dodecyl sulphate (SDS), 
ammonium persulphate (APS), N,N,N’,N’ tetramethylethylenediamine (TEMED), 
Bovine serum albumin (BSA), acrylamide, N,N’ methylenebisacrylamide, 
Bicinchoninic acid (BCA), Pierce Modified Lowry protein assay reagents, 3,3’-
diaminobenzidine tetrahydrochloride (DAB), and Tween-20 were obtained from 
Thermo Fisher Scientific (Waltham, MA). Goat anti-(rabbit-IgG or mouse-IgG) 
conjugated to horse-radish peroxidase, chromatography columns, and 
nitrocellulose membrane were obtained from Bio-Rad Laboratories (Hercules, 
CA). SuperSignal West Pico PLUS Chemiluminescent western blotting detection 
substrates was obtained from Pierce (Rockford, IL). A rabbit polyclonal CD36 
and mouse monoclonal ABHD5 (CGI-58) antibodies were obtained from Abnova 
(Jhongli, Taiwan). A rabbit polyclonal tyrosine hydroxylase (TH) antibody was 
obtained from Novus Biologicals, LLC. (Littleton, CO). A polyclonal UCP1 
antibody was obtained from Abcam Biotechnology Company (Cambridge, United 
Kingdom). A polyclonal glyceraldehyde 3-phosphate dehydrogenase (GAPDH) 
antibody, isoproterenol, 4-methylumbelliferyl heptanoate (4-MUH), free glycerol 
reagent, and triglyceride reagent were purchased from Sigma-aldrich (St. Louis, 
MO). Half Micro Test Kit for free fatty acid assay was obtained from Roche 
Pharmaceutics Company (Basel, Switzerland). Contour glucose test kit and test 
strips were purchased from Bayer Pharmaceutics Company (Leverkusen, 
Germany). Enzymatic assay kits for total cholesterol, free cholesterol, and 
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phospholipids were obtained from Wako (Richmond, VA). CL-243,316 was 
purchased from Tocris Bioscience (Bristol, United Kingdom). C14-2-Deoxyglucose 
and H3-2-Deoxyglucose were obtained from PerkinElmer (Waltham, MA). 
VECTASSTAIN Elite ABC HRP Kit (Peroxidase, Rabbit IgG) was obtained from 
Vector Laboratories (Burlingame, CA). Hematoxylin Stain Gill 2 was obtained 
from Ricca Chemical Company (Arlington, TX). Quanti-iTTM dsDNA Assay Kit 
was obtained from Invitrogen (Eugene, Oregon).  
 
Table 1. Primers used to amplify mRNAs encoding targeted mouse genes.   
Name Forward (5’ to 3’) Reverse (5’ to 3’) 
ANP CAAGAACCTGCTAGACCACC AGCTGTTGCAGCCTAGTCC 
BNP CCAGAGACAGCTCTTGAAGG TCCGATCCGGRCTATCTTG 
CD36 GGAACTGTGGGCTCATTGC CATGAGAATGCCTCCAAACAC 
CPT1α TGAGTGGCGTCCTCTTTGG CATGAGAATGCCTCCAAACAC 
Dio2 GTCCGCAAATGACCCCTTT CCCACCCACTCTCTGACTTTC 
FATP1 CCGTATCCTCACGCATGTGT CTCCATCGTGTCCTCAATGAC 
Glut1 GGTGTGCAGCAGCCTGTGTA CAACAAACAGCGACACCACAGT 
Glut4 CCGGCAGCCTCTGATCAT CCGACTCGAAGATGCTGGTT 
LPL ACTCTGTGTCTAACTGCCACTTCAA ATACATTCCCGTTACCGTCCAT 
PGC1α GACTCAGTGTCACCACCGAAA TGAACGAGAGCGCATCCTT 
PRDM16 CAGCACGGTGAAGCCATTC GCGTGCATTCGCTTGTG 
PPAR-α GCCTGTCTGTCGGGATGT GGCTTCGTGGATTCTCTTG 
PPAR-γ GCCCTTTGGTGACTTTATGGA GCAGCAGGTTGTCTTGGATG 
UCP1 AAGCTGTGCGATGTCCATGT AAGCCACAAACCCTTTGAAAA 
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SCD1 CCGGAGACCCCTTAGATCGA TAGCCTGTAAAAGATTTCTGCAAACC 
SirT1 GATGACGATGACAGAACGTCACA GGATCGGTGCCAATCATGAG 
GAPDH ACCACAGTCCATGCCATCAC CACCACCCTGTTGCTGTAGCC 
18s RNA GGGAGCCTGAGAAACGGC GGGTCGGGAGTGGGTAATTT 
 
Methods 
Animals and Diets 
Brown adipose-specific CGI-58 knockout (BAT-KO) mice were produced by 
crossing CGI-58-floxed mice generated in our lab previously [216] with B6.FVB-
Tg (Ucp1-cre) 1 Evdr/J mice (The Jackson Laboratory, Stock #: 024670) 
generated by Dr. Evan Rosen’s lab at Harvard Medical School. The Ucp1-cre 
mice specifically express cre recombinase in UCP1 positive cells, leading to 
selective inactivation of gene expression in brown and beige adipocytes [217]. 
Homozygous CGI-58 floxed mice without Ucp1-cre transgene were used as 
controls for all experiments.  
Whole adipose tissue CGI-58 knockout (FAT-KO) mice were generated by 
crossing our CGI-58-floxed mice with adiponectin-cre mice [B6;FVB-Tg(Adipoq-
cre)1Evdr/J mice, The Jackson Laboratory, Stock #: 010803] generated by Dr. 
Evan Rosen [218]. The adiponectin-cre mice express cre recombinase in all 
adipose tissues, thus inactivating gene expression in whole adipose tissue. 
Homozygous CGI-58 floxed mice without adiponectin-cre transgene were as 
controls for all experiments. 
Mice were housed in a pathogen-free animal facility at 22oC with a 12h 
light/dark cycle from 6AM to 6PM and fed ad libitum a standard chow diet 
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(LabDiet) or a high fat diet (HFD) containing 60% energy from fat, 20% energy 
from carbohydrate, and 20% energy from protein (D12492, Research Diets Inc.). 
Diet treatments and weight measurements were started at 6 weeks of age. All 
animal experiments were performed with male mice and approved by the 
Institutional Animal Care and Use Committees (IACUC) at the University of 
Maryland at College Park and at Georgia State University.  
Body Weight and Food Intake 
 Body weight was monitored weekly on Wednesday at 10 AM from the 
beginning of diet treatment (6 weeks of age) until 17-18 week of diet treatment. 
On the 5th week of diet treatment, mice were individually caged and measured 
food intake daily for 7 days.  
Metabolic Phenotyping and Telemetry 
Indirect Calorimetry (Oxymax/ CLAMS, Columbus Instruments, Columbus, 
OH) was used to measure energy expenditure, respiratory exchange ratio (RER), 
and physical activity in mice at 22oC, 30oC, or 30oC combined with intraperitoneal 
(i.p.) injections of 3 agonist CL-316,243 at 0.1 mg/kg body weight. The core 
body temperature was continuously monitored by Telemetry (Mini Mitter/Philips 
Respironics, Bend, OR; ER4000 energizer/receivers, G2 E-mitters implanted 
intraperitoneally). Rectal temperature was monitored in some mice subjected to 
acute cold exposure using Thermalert TH-5 device (Physitemp). Food intake was 
measured in metabolic chambers. Body composition was determined by using by 
EchoMRI-100H Body Composition Analyzer (EchoMRI LLC.). For chronic cold 
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exposure, we allowed 2-4 days of acclimation to different housing environment to 
finally mice to adapt 4oC.   
CL-316,243 and Saline Injection for mimicking chronic cold 
CL-316,243 (1 mg/kg body weight) or saline were administered i.p. to 14-week-
old HFD-fed mice (8 weeks on HFD). Injection was performed at 10 AM daily for 
4 days. Following consecutive injection, mice, on day 5, were sacrificed without 
additional injection.  
In vivo Lipolysis Assays 
The mice were injected i.p. with isoproterenol at 10 mg/kg body weight around 
10AM. Blood samples were collected before and 15 min after isoproterenol 
injection. Collected blood were centrifuged for 15 min at 2500 RPM. Plasma 
concentrations of FFA and glycerol were analyzed by enzymatic assay.  
BAT Hydrolysis Assays 
Snap-frozen brown adipose tissues were quickly weighed, homogenized in ice-
cold Tris-HCl homogenization buffer (50 mM, pH 7.4, 250 mM sucrose, 1 mM 
EDTA), and sonicated briefly. Protein contents in homogenates were analyzed 
using BCA assay. Hydrolytic activity were assessed by mixing 20 µl of 2 µg total 
protein containing homogenates, 20 µl of 5 µM 4-MUH in reaction buffer (20 mM  
Tris-HCl, pH 8.0, 1mM EDTA, 300 µM taurodeoxycholate), and 60 µl of the 
reaction buffer in 96-well plates and incubating at room temperature with shaking 
for 5 min. The fluorescence was continuously recorded over a 10 min period at 
355 nm as excitation and 460 nm as emission wavelengths at 22oC [219].           
Immunohistochemistry of Tissues 
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The iWAT was fixed in 10% formalin solution, paraffin-embedded, and then 
sectioned at 5 µm thickness. The sections were deparaffinized and rehydrated, 
followed by antigen retrieval using 10 mM sodium citrate (pH 6.0) for 20 min. 
After antigen retrieval, non-specific sites were blocked by incubating the sections 
in TBS containing 10% normal goat serum and 0.2% Tween 20 for 40 min. The 
sections were then incubated with the primary antibody against UCP1 (1:200) or 
TH (1:200) for overnight at 4oC, followed by three washes, 5 min each, with TBS-
Tween 20 solution and incubation for 1h with a biotinylated secondary antibody 
(1:200). After three washes, the sections were incubated with the reagents in 
VECTASSTAIN Elite ABC HRP Kit for 30 min and then with DAB for 5-10 min. 
After three washes, cell nuclei were stained with hematoxylin. The sections were 
dehydrated, sealed, and examined under a microscope.  
Glucose Tolerance and Insulin Tolerance Tests 
For glucose tolerance test (GTT), the mice were fasted overnight (16h) and then 
injected i.p. with glucose solution at 1.5 g/kg body weight. Blood glucose 
concentrations were measured at 0, 15, 30, 60, and 120 min after glucose 
injection. For insulin tolerance test (ITT), the mice were fasted for 6h during the 
daytime cycle, followed by an intraperitoneal injection of recombinant human 
insulin in saline at a dose of 0.75 U/kg body weight. Blood glucose levels were 
monitored at 0, 15, 30, 60 and 120 min after insulin injection.  
Analysis of Adipocyte Size 
The adipose tissue cell sizing was done in osmium-fixed urea-isolated adipocytes 
as described previously [220] with some modifications. Briefly, the adipose 
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tissues from different fat depots of the mice on HFD for 17 weeks were excised 
aseptically, sliced to ~50 mg in size and rinsed twice in 0.154M NaCl at 37oC to 
wash off free lipids on the tissues. The tissue slices were transferred to 
scintillation vials containing 1.2 mL of 50mM Colloidine HCl buffer and 2 mL of 
3% osmium tetroxide in 0.05 M Colloidine HCl buffer (pH 7.4 at 37oC). The 
sample vials were kept in a ventilated fume hood at room temperature for 72h. 
The osmium-colloidine buffer was removed and replaced by 10 mL of 0.154M 
NaCl for 24h. Subsequently, 10mL 8M Urea in 0.154M NaCl was added to the 
sample vials and the vials were intermittently swirled by hand and kept in room 
temperature for 48h. This solubilized the connective tissue in the adipose tissue 
slices resulting in a suspension of adipocyte cells. The adipocyte cell suspension 
was passed through 250µM nylon membrane to remove any of the remaining 
tissue debris. The cells were rinsed with 0.01% Triton-X in distilled water and 
then used to profile cell size distribution using Multisizer® Coulter Counter 
(Beckman coulter Ireland Inc.).  
Tissue Lipid Analysis  
Total lipids were extracted as described previously [221]. To determine tissue 
lipid concentrations, about 40~50 mg of liver piece or 20~30 mg of adipose 
tissues were sliced and extracted with 1:1 CHCl3/MeOH. The organic phase was 
analyzed for lipid species. Samples were allowed to stay at room temperature 
overnight to ensure extraction of lipid until the tissue sink at the bottom of the 
tube. Extractions were centrifuged at 2,000 xg for 15 min at room temperature. 
The lipid phase was transferred into a new tube, leaving the delipidated tissue 
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behind for protein determination. Delipidation process was repeated with 
additional CHCl3/MeOH. Lipid extraction was dried down under N2 at 60oC. 
Additional CHCl3/MeOH was added and sit on heating blocks at 60oC for 5 min to 
solubilize the lipid. To split the phases, 0.6ml of 0.05% H2SO4 was then added. 
Samples were centrifuged at 2,000 xg for 15 min at room temperature. Bottom 
phase was transferred to new glass tube, mixed with 1% TritonX-100, and dried 
down under N2 gas. 0.5ml dH2O was added and tubes were placed on heating 
block for 5 min. Samples went vortex until solution appeared clear. 
Concentrations of TC, FC, and TG in each sample were used to determine by 
enzymatic assay kit described in the material section. Protein concentrations in 
the delipidated samples were determined using a Lowry assay [222]. 
Glucose Uptake Assays 
To measure insulin-stimulated glucose uptake, the mice were fasted overnight 
(16h), and then injected with human insulin at 0.75 mU/Kg and 10 µCi of C14-2-
Deoxyglucose (2-DG). Forty-five minutes after 2-DG injection, the mice were 
sacrificed and tissues collected. For cold-induced glucose uptake, overnight 
fasted mice were exposed to cold (4oC) for 30 min before injection of 10 µCi of 
[3H]-2-DG as a tracer and then sacrificed for tissue collection after additional 45 
min cold exposure. DG is transported into tissues and phosphorylated to 2-
deoxyglucose 6-phosphate (2-DGP). Tissue contents of 2-DGP were used to 
reflect their glucose uptake efficiency. To determine tissue 2-DGP content, 
samples were homogenized and 2-DGP was separated from 2-DG using ion 
exchange column, and then 2-DGP was counted.  
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Protein Extraction and Immunoblotting 
The tissues were homogenized and lysed for 30 min in RIPA buffer containing 
0.1% SDS with a protease and phosphatase inhibitor cocktail, followed by 
sonication and centrifugation. To avoid fat contamination, a 26G1/2 syringe was 
used to collect the supernatant. The protein concentration of the supernatant was 
determined using a bicinchoninic acid (BCA) kit. For immunoblotting, proteins in 
the supernatant were denatured by heating, separated by SDS-PAGE, and then 
transferred onto a nitrocellulose membrane. The membrane was incubated in a 
5% non-fat milk blocking buffer (TBS-Tween 20) for 1h, followed by incubation 
with a primary antibody in TBS-Tween 20 containing 5% BSA for overnight at 
4oC. After 3 washes with TBS-Tween 20, the membrane was incubated with a 
goat-anti-rabbit or goat-anti-mouse IgG conjugated horse radish-peroxidase 
secondary antibody in a 5% non-fat milk TBS-Tween 20 for 1h, washed three 
times with TBS-Tween 20, and developed with Enhanced Chemiluminescence 
Detection Reagents. The protein signals were imaged using a Bio-Rad 
ChemiDoc System.  
Quantitative Real-Time Polymerase Chain Reaction (qPCR) 
Total RNAs were isolated using TRIzol® Reagents. RNAs were reverse 
transcribed into cDNA using TaqMan® Reverse Transcription Reagents (Applied 
Biosystems) and tissue mRNA levels were determined by qPCR using 
Stratagene Mx3005p PCR machine (Agilent Technologies). Reactions were done 
in duplicate for each biological sample using SYBR® Green Real-Time PCR 
Master Mix (Invitrogen). The relative mRNA expression level for each gene was 
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calculated by the 2(-DDCt) method and normalized to GAPDH or 18s rRNA, which 
was arbitrarily set to 1. Primer sequences are listed in table 1.  
Statistical Analysis 
Data are expressed as Mean ± SEM, and were tested for statistical significance 
by Two-way ANOVA with Bonferroni post hoc tests when both genotypes and 
treatments were considered, or by Student t-tests when the two genotypes were 
compared. The p value less than 0.05 was considered statistically significant. 
Data were analyzed using Grad Pad software and SAS version 9.2 (SAS 
Institute, Inc.).  
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In Brief  
Shin et al. show that mice lacking BAT CGI-58, an ATGL coactivator critically 
implicated in cytosolic lipid droplet lipolysis, are not cold sensitive due to 
increased combustion of circulating thermogenic fuels and WAT browning. WAT 
lipolysis is essential to fuel thermogenesis during fasting.  
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Summary  
Brown adipose tissue (BAT) lipid droplet (LD) lipolysis was believed to play a 
central role in non-shivering thermogenesis, but this concept has not been tested 
in vivo. Here we show that mice lacking BAT Comparative Gene Identification-58 
(CGI-58), a coactivator of Adipose Triglyceride Lipase (ATGL), are not cold 
sensitive. When CGI-58 is inactivated in both BAT and white adipose tissue 
(WAT), mice become cold sensitive only in the fasted, but not fed state. BAT-
specific knockout (BAT-KO) mice versus controls display higher body 
temperature when food is present during cold exposure, which is associated with 
increases in BAT glucose uptake, WAT browning, total energy expenditure, and 
adipose sympathetic innervation. Thus, BAT LD lipolysis is not essential for cold-
induced thermogenesis in vivo. Our data uncover a key role of BAT lipolysis in 
regulating compensatory cold adaptation mechanisms and suggest a critical role 
of WAT lipolysis in provision of thermogenic fuels during fasting.  
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Introduction  
Adipose tissues can be broadly divided into two types, brown adipose 
tissue (BAT) and white adipose tissue (WAT). While rodents and human infants 
have visible classical BAT depots, it was once thought adult humans lack BAT. 
Recent re-discovery of BAT-like tissues in adult humans through the use of 
positron emission tomography (PET)-scanning technology has revitalized interest 
in basic and clinical research of BAT biology (Cypess et al., 2009; van Marken 
Lichtenbelt et al., 2009; Virtanen et al., 2009). A major function of BAT is to 
defend against cold in a nonshivering manner by generating heat from free fatty 
acids (FFAs), glucose and perhaps other chemicals (Cannon and Nedergaard, 
2004; Kazak et al., 2015; Ozaki et al., 2011; Shabalina et al., 2013). Uncoupling 
protein 1 (UCP1) plays a key role in this adaptive thermogenesis by uncoupling 
mitochondrial oxidation of substrates from ATP synthesis (Cannon and 
Nedergaard, 2004).  
Recently a distinct population of adipocytes that exist in WAT contain 
multiple lipid droplets (LDs) and express UCP1 were named brown-like (beige) or 
brown-in-white (brite) adipocytes (Petrovic et al., 2010; Wu et al., 2012). 
Although origins of beige adipocytes are under debate, they are functionally 
thermogenic (Shabalina et al., 2013). The process of beige adipocyte recruitment 
to WAT is called WAT browning, which is often induced by cold exposure or 
stimulation with a sympathetic agonist (Nedergaard and Cannon, 2014; Rosen 
and Spiegelman, 2014). Rodents clearly have “classical” brown adipocytes and 
beige/brite adipocytes. Humans may possess both brown and beige adipocytes 
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(Jespersen et al., 2013), or largely beige adipocytes (Sidossis and Kajimura, 
2015). Besides their endocrine functions, brown/beige and white adipocytes 
mainly function to dissipate and store energy, respectively, in response to 
environmental and nutritional fluctuations.  
BAT activity is mainly controlled by the sympathetic nervous system (SNS) 
(Cannon and Nedergaard, 2004). Stimulation of SNS releases norepinephrine 
(NE) to increase intracellular cyclic AMP (cAMP) by activating adenylyl cyclase in 
the adrenergic signaling pathway. In mature brown adipocytes, NE-induced 
formation of cAMP seems to be fully mediated via β3-adrenergic receptor (Zhao 
et al., 1994). Thus, a selective β3-adrenoreceptor agonist CL-316,243 is often 
used to mimic cold exposure to activate BAT activity. Increases in cellular cAMP 
activate protein kinase A (PKA) that phosphorylates a transcriptional factor 
cAMP-response-element binding protein (CREB) (Thonberg et al., 2002), 
resulting in transcriptional activation of thermogenic genes including UCP1 
(Kozak et al., 1994). Activation of PKA promotes intracellular lipolysis (Honnor et 
al., 1985) that supposedly provides FFAs for brown adipocytes to produce heat. 
It was assumed that cytosolic LD lipolysis is central to understanding the control 
of nonshivering thermogenesis (Cannon and Nedergaard, 2004), but this 
assumption has not been directly tested in vivo due to lack of appropriate animal 
models.  
To address this long outstanding question, we created BAT-specific 
Comparative Gene Identification-58 (CGI-58) knockout (BAT-KO) mice. CGI-58, 
also known as Abhd5 (the fifth member of α/β-hydrolase fold protein family), is a 
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LD-associated protein that is critically implicated in cytosolic LD lipolysis through 
interacting with LD coat proteins (Liu et al., 2004; Subramanian et al., 2004; 
Yamaguchi et al., 2004) and serving as a coactivator of Adipose Triglyceride 
Lipase (ATGL) (Lass et al., 2006). Like ATGL, CGI-58 is ubiquitously expressed 
with the highest expression in adipose tissues (Lass et al., 2006; Subramanian et 
al., 2004). In this study, we found that BAT-KO mice are not cold sensitive even 
in the fasted state. They display unaltered expression of UCP1 mRNA/protein 
and increased expression of fatty acid and glucose transporters in the 
interscapular BAT (iBAT) as well as increased subcutaneous WAT browning. We 
also found that mice lacking CGI-58 in all adipose tissues (FAT-KO mice) are 
cold sensitive only in the fasted, but not fed state, which is different from a 
previous study that concluded that intracellular lipolysis is essential for cold-
induced thermogenesis and brown phenotypes (Ahmadian et al., 2011). 
Comparison of cold tolerance between mice lacking CGI-58 in BAT only and 
those lacking CGI-58 in all adipose tissues reveals an important role of WAT 
lipolysis in cold adaptation during fasting. Thus, our studies establish a new 
paradigm that LD lipolysis in brown adipocytes is not required for sustaining 
whole-body thermogenesis, but rather plays a critical role in regulating 
compensatory thermogenic mechanisms during cold adaptation.  
 
Results  
BAT-Specific Deletion of CGI-58 Induces BAT Steatotic Hypertrophy and 
Hyperplasia  
- 41 - 
 
To identify the role of brown adipocyte LD lipolysis in thermogenesis and 
metabolic health, we generated BAT-KO mice by crossing CGI-58-floxed mice 
(Guo et al., 2013) with Ucp1-cre transgenic mice (Kong et al., 2014) as described 
in Methods. As reported by others using the same Cre mouse line (Kong et al., 
2014), BAT-specific deletion was achieved (Figure S1A). BAT-KO versus control 
mice on chow or HFD gained weight similarly and had similar energy intake 
(Figure 1A and 1B). They appeared grossly normal except a visible hump on the 
upper back, which was caused by enlarged iBAT that appeared like WAT (Figure 
1C). The white fat appearance was attributable to large cytosolic LD 
accumulation resulting in a ~2-fold increase in average adipocyte size (steatotic 
hypertrophy) (Figure 1D and 1E). In addition, the total amount of DNA in CGI-58-
deficient iBAT relative to controls was increased by 2.1 folds (Figure 1F), though 
the DNA amount per mg BAT was decreased by 56% (Figure S1B). Similar 
changes were observed for BAT proteins (Figure 1G and S1C). These changes 
are consistent with the increased total cell number (hyperplasia) in CGI-58-
deficient iBAT. Steatotic hypertrophy and hyperplasia of CGI-58-deficient iBAT 
together resulted in a 4.3-fold increase of its weight on average (Figure 1H). 
Increased BAT did not cause changes in body composition in BAT-KO mice 
(Figure S1D), which may largely attribute to significant decreases in weights of 
other fat depots, including iWAT, eWAT and mesenteric WAT (mWAT), though 
not peri-renal WAT (pWAT) (Figure 1H). As expected, the TG content was 
increased by 2.4 folds in CGI-58-deficient iBAT (Figure 1I). It has been well 
established that CGI-58 deficiency causes cytosolic TG-rich LD accumulation by 
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inhibiting intracellular lipolysis (Brown et al., 2007; Lass et al., 2006). 
Consistently CGI-58-deficient iBAT had significantly reduced lipase activity 
(Figure 1J). The lipase activity left in CGI-58-deficient BAT may reflect that from 
hormone-sensitive lipase (HSL), which is capable of hydrolyzing TG in vitro to 
some extent (Sztalryd et al., 1995), and that from cell types other than brown 
adipocytes, which constitutes about 50% of BAT (Rosenwald et al., 2013). 
Nonetheless, BAT CGI-58 deficiency suffices to cause cytosolic LD accumulation 
demonstrating its crucial role in cytosolic LD dynamics. Interestingly, the TG 
content was decreased in iWAT and mWAT (Figure 1I) suggesting a 
compositional change of these white fat depots in BAT-KO mice. Decreased 
WAT mass and TG content may contribute to reduced capacity of these animals 
to release FFA and glycerol following lipolytic stimulation by isoproterenol (Figure 
1K), but fold increases in FFA and glycerol release after isoproterenol injection 
were similar between the two genotypes (Figure 1K), suggesting that WAT’s 
responsiveness to lipolytic stimulation is reserved in BAT-KO mice.  
A major function of BAT is to dissipate energy as heat. To determine if 
CGI-58 deletion in thermogenic BAT influences whole-body energy balance and 
body temperature, we performed metabolic phenotyping using Indirect 
Calorimetry and Telemetry. BAT-KO mice showed a moderate, but significant 
reduction in total energy expenditure at room temperature (22oC), but not 
thermoneutrality (30oC) (Figure S1E). There were no significant changes in 
oxygen consumption, respiratory exchange ratio (indicative of metabolic 
substrate preference), total physical activity, food intake, and core body 
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temperature between BAT-KO and control mice housed at either room or 
thermoneutral temperature (Figure S1E). As expected, thermoneutrality reduced 
total energy expenditure, oxygen consumption and increased respiratory 
exchange ratio in normal mice. Similar responses were reserved in BAT-KO mice 
(Figure S1E). These findings demonstrate that BAT lipolysis has limited impact 
on whole-body energy balance and thermogenesis at room temperature (a mild 
cold condition) and thermoneutrality.  
 
BAT CGI-58 Deficiency Does Not Cause Cold Intolerance  
To determine whether defective LD lipolysis in BAT influences cold-
induced thermogenesis, we subjected chow-fed BAT-KO mice to acute cold 
exposure (4oC) and monitored their intra-rectal temperature changes. We found 
that BAT-KO mice were not cold sensitive even when food was absent during 
cold exposure (Figure 2A). Interestingly BAT-KO mice versus controls on chow 
displayed higher body temperature when food was present during acute cold 
exposure (Figure 2B). Similar responses were observed in HFD-fed mice when 
the core body temperature was continuously measured by Telemetry (Figure 2D 
and 2E). During chronic cold exposure when mice had free access to food and 
water, the core body temperature was significantly higher in BAT-KO than control 
mice in the first 2 days (Figure 2F). It stayed higher from Day 3 to Day 7 of cold 
exposure, though the level did not reach statistical significance (Figure 2F). In 
addition to their normal or better cold tolerance, BAT-KO mice also showed no 
changes in total energy expenditure during acute cold exposure regardless of 
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food availability, or higher total energy expenditure during chronic cold exposure 
(Figure S2A). The maintenance of body temperature and energy expenditure in 
cold-exposed BAT-KO mice was not a result of increased physical activity 
(Figure S2B).  
 
UCP1 Protein Is Not Reduced in CGI-58-Deficient BAT  
BAT thermogenesis is mainly governed by UCP1 (Cannon and 
Nedergaard, 2004). It was reported that iBAT UCP1 expression was reduced in 
adipose lipolysis-deficient mice (i.e., mice lacking ATGL in all adipose tissues) 
and this reduction in UCP1 expression was used to explain cold-sensitive 
phenotypes in these animals (Ahmadian et al., 2011). However, we did not 
observe a significant reduction of UCP1 protein expression in the iBAT of BAT-
KO mice on chow diet (Figure 3A). Considering a ~50% increase of the total 
proteins in the CGI-58-deficient relative to control iBAT (Figure 1G), the total 
amount of UCP1 protein was actually increased. To gain additional information 
about why mice deficient in BAT lipolysis are not cold sensitive, we measured 
iBAT expression levels of UCP1 and other genes related to thermogenesis in 
mice treated with the β3 agonist CL-316,243 for 4 days or cold for 7 days. Under 
the basal condition, i.e., mice housed at room temperature without β3 agonist or 
cold treatment, iBAT UPC1 mRNA and protein levels did not differ between the 
two genotypes (Figure 3B-3E). Interestingly, the protein expression of tyrosine 
hydroxylase (TH), a marker of sympathetic innervation (Foster and Bartness, 
2006), was substantially increased in CGI-58-deficient iBAT (Figure 3D) 
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suggesting augmented sympathetic drive under this condition, which may explain 
its hyperplasic phenotype (Figure 1F) and reserved UCP1 expression. CGI-58 
deficiency also had no effects on iBAT expression of mRNA for peroxisome 
proliferator-activated receptor (PPAR)-α (Figure 3B), a gene critical in regulation 
of mitochondrial fatty acid oxidation and functions, and mRNA for PR domain-
containing 16 (PRDM16) (Figure 3B), a transcription coregulator that controls 
brown adipocyte development and adipocyte thermogenic program (Seale et al., 
2008; Seale et al., 2011). Interestingly, the mRNAs for PPAR-γ coactivator 
(PGC)-1α and type II iodothyronine deiodinase (Dio2), two genes relevant to 
thermogenesis (de Jesus et al., 2001; Wu et al., 2012), were significantly 
elevated in CGI-58-deficient iBATs (Figure 3B). These results, together with 
normal cold tolerance of BAT-KO mice, imply that the thermogenic machinery is 
intact in CGI-58-deficient iBAT. Despite this, UCP1 protein expression in the 
CGI-58-deficient iBAT did show a blunted response to β3 agonist (Figure 3C) or 
cold (Figure 3D). However, the total amount of UCP1 protein in the CGI-58-
deficient iBAT remained largely unchanged due to a ~50% increase of the total 
protein content in this iBAT relative to controls (Figure 1G). Overall, our results 
indicate that BAT CGI-58 deficiency does not reduce its total amount of UCP1 
protein.  
 
CGI-58-Deficient BAT Increases Combustion of Blood Substrates for Cold-
Induced Thermogenesis  
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Brown adipocytes may directly use FFA, glucose and other chemicals 
derived from the blood circulation as thermogenic substrates without firstly 
storing them in cytosolic LDs, though it was reported that utilization of TG stored 
in cytosolic LDs of brown adipocytes plays a predominant role in acute cold-
induced thermogenesis (Ma and Foster, 1986; Ouellet et al., 2012). In the fed 
state, diet is obviously a major source of energetic substrates present in the 
blood. BAT-KO mice had increased calorie intake during cold exposure (Figure 
4A), which may be a compensatory mechanism when LD lipolysis is inhibited in 
brown adipocytes. The respiratory exchange ratio (RER) was significantly higher 
in BAT-KO mice during the first 5 days of cold exposure (Figure 4B), indicating 
increased combustion of carbohydrates during this period. To provide direct 
evidence in support of increased carbohydrate utilization for cold-induced 
thermogenesis in BAT-KO mice, we examined glucose-initiated thermogenesis 
during acute cold exposure. After a bolus of glucose, blood glucose levels 
remained remarkably lower and the intra-rectal temperature was significantly 
higher in BAT-KO mice than controls (Figure 4C and 4D). These observations 
are consistent with increased glucose uptake by iBAT as an organ during acute 
cold exposure (Figure 4E) as well as augmented expression of iBAT mRNA for 
glucose transporter 1 (Glut1) (Figure 4F). The mRNA for glucose transporter 4 
(Glut4), which is responsible for insulin-stimulated glucose uptake, was 
decreased in the CGI-58-deficient iBAT (Figure 4F). The insulin-stimulated 
glucose uptake per mg wet tissue was not significantly altered in adipose and 
muscle tissues (Figure S3), except CGI-58-deficient iBAT whose total glucose 
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uptake should be considered elevated because of its increased wet weight 
(Figure 1H).  
Compared to glucose, FFAs are energy-rich molecules and normally the 
major fuels for thermogenesis (Cannon and Nedergaard, 2004). CD36, 
lipoprotein lipase (LPL) and fatty acid transporter 1 (FATP1) play important roles 
in iBAT uptake and transport of FFAs (Bartelt et al., 2011; Wu et al., 2006). We 
observed that iBAT levels of mRNAs for CD36 and LPL, tbut not FATP1, were 
significantly increased in BAT-KO mice (Figure 4G). The iBAT expression level of 
CD36 protein, a fatty acid transporter critically implicated in cold-induced 
thermogenesis (Bartelt et al., 2011), was substantially higher in BAT-KO mice 
than controls during cold exposure or after CL-316,243 treatment (Figure 4H). 
These findings imply that CGI-58-deficient BAT may have increased FFA uptake 
from the blood, especially during cold adaptation. Collectively our results suggest 
that CGI-58-deficient BAT reprograms its metabolism to increase combustion of 
blood fuels including glucose and perhaps FFAs for thermogenesis.  
 
WAT Lipolysis Is Essential for Thermogenesis During Fasting  
When BAT-KO mice can use dietary nutrients to fuel thermogenesis in the 
fed state, they must use endogenous fuels during fasting. Fasting mobilizes 
energy stores mainly by inducing hepatic glycogenolysis and WAT lipolysis. It 
has been shown that mice lacking ATGL globally or in all adipose tissues are 
cold sensitive (Ahmadian et al., 2011; Haemmerle et al., 2006) suggesting a 
critical role of adipose lipolysis in cold-induced thermogenesis. Given the normal 
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cold tolerance of mice lacking CGI-58 selectively in BAT during fasting (Figure 2), 
we hypothesized that WAT lipolysis is essential to fuel thermogenesis during 
fasting. To test this hypothesis, we created a mouse line with CGI-58 inactivation 
in both BAT and WAT (FAT-KO mice) (Figure S4A). FAT-KO mice showed no 
alterations in weight gain and food intake despite increased fat mass and weights 
of all adipose depots (Figure 5A-D). Like BAT-KO mice, FAT-KO mice also 
showed an enlarged white fat-looking iBAT (Figure 5E) and large LD deposition 
in iBAT adipocytes (Figure 5F) resulting in increased brown adipocyte size 
(Figure 5G). Their iBAT relative to controls also had higher total amounts of 
DNAs and proteins, though the DNA and protein contents per mg iBAT were 
decreased (Figure S4B). As expected, FAT-KO mice were completely resistant to 
lipolysis stimulation (Figure 5H). The failure of an adrenergic agonist to stimulate 
lipolysis in FAT-KO mice highlights the essential role of CGI-58 in mediating 
cytosolic LD lipolysis. Like mice lacking ATGL globally (Haemmerle et al., 2006), 
FAT-KO mice housed at ambient temperature also developed hypothermia 
during fasting (Figure 5I). They were cold sensitive when food was removed 
during cold exposure (Figure 5J). Since mice lacking CGI-58 in BAT only are not 
cold sensitive during fasting, our results indicate that it is WAT lipolysis that fuels 
thermogenesis in these animals in the fasted state.  
Despite cold intolerance during fasting, FAT-KO mice were able to tolerate 
cold when food was present (Figure 5J), suggesting that inhibiting adipose 
lipolysis causes cold intolerance by limiting thermogenic substrates, not by 
impairing thermogenic machinery (brown phenotypes). Consistently, iBAT UCP1 
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protein and mRNA levels normalized to GAPDH were not changed in FAT-KO 
mice fed a HFD (Figure 5K and 5L), a chow diet, or a chow diet coupled with β3 
agonist treatment (Figure S4C). Considering the increased total DNA and protein 
contents in CGI-58-deficient iBAT relative to control iBAT (Figure S4B), the total 
amounts of UCP1 protein and mRNA were actually elevated in this organ. When 
the HFD-fed mice were treated with the β3 agonist CL-316,243, we did see a 
lower UCP1 protein expression level in the CGI-58-deficient iBAT after 
normalization to the amount of GAPDH protein (Figure S4D). Again, given the 
increased relative protein content, the total amount of UCP1 protein in CGI-58-
deficient iBAT was largely unchanged. Taken together, our results indicate that 
adipose lipolysis deficiency does not reduce the total amount of UCP1 protein in 
BAT, which may explain why adipose lipolysis-deficient mice including our FAT-
KO mice and adipose tissue-specific ATGL knockout mice (the manuscript 
submitted to Cell Metabolism by Drs. Renate Schreiber and Rudolf Zechner) are 
not cold sensitive in the fed state.  
 
CGI-58 Deletion in BAT Enhances WAT Browning  
Cold-exposed BAT-KO mice exhibit higher body temperature when food is 
available (Figure 2). This phenomenon seems to suggest a higher setting point of 
whole-body thermogenesis in BAT-KO mice, which may be achieved through 
chronic activation of multiple compensatory thermogenic mechanisms. WAT 
browning is an important cold adaptive mechanism (Nedergaard and Cannon, 
2014; Rosen and Spiegelman, 2014). To examine this possibility, we examined 
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the morphology of iWAT, a fat pad sensitive to browning factors. Indeed, BAT-KO 
versus control mice housed at room temperature (a moderate cold condition 
compared to thermoneutrality), exposed to cold, or treated with the β3 agonist 
CL-316,243 for 4 days all showed augmented browning as evidenced by 
increased emergence of adipocytes containing multilocular LDs (Figure 6A) and 
enhanced UCP1 immunohistochemical staining (Figure 6B) in the iWAT. 
Increased browning of BAT-KO mice was further supported by elevated UCP1 
mRNA and protein levels in the iWAT after chronic cold exposure or β3 agonist 
treatment (Figure 6C and 6D). Under the basal condition (22oC and saline 
treatment), iWAT UCP1 mRNA expression was also significantly increased in 
BAT-KO mice when Student-t-test not Two-way ANOVA was used for statistical 
analysis (Figure 6C).  
Adipose browning can be induced by increased sympathetic innervation 
and/or direct actions of humoral and hormonal factors on adipocytes (Cannon 
and Nedergaard, 2004; Wu et al., 2013). We observed that TH protein 
expression was substantially increased in the iWAT of BAT-KO mice housed at 
room temperature or exposed to cold for 7 days (Figure 6E), suggesting that 
lipolysis deficiency in BAT enhances WAT browning, at least in part, by 
increasing sympathetic drive.  
 
BAT CGI-58 Deficiency Improves Metabolic Profiles in Mice on HFD  
Both brown and beige adipocytes contribute to handling of fatty acids and 
glucose in humans (Orava et al., 2011; Ouellet et al., 2012). It was recently 
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demonstrated that BAT plays a critical role in triglyceride clearance from the 
blood circulation in mice during cold exposure (Bartelt et al., 2011). To examine 
whether inhibition of LD lipolysis selectively in BAT, a major energy-dissipating 
organ, has any effects on overnutrition-induced metabolic disorders such as 
glucose tolerance, insulin resistance and hepatic steatosis, we fed BAT-KO and 
control mice a HFD. It was found that BAT-KO mice tolerated glucose better 
(Figure 7A), had reduced fasting HOMA insulin resistance index [(glucose at 
mg/dL x insulin at µIU/mL)/22.5] (Figure 7B) due to significantly reduced plasma 
insulin and a trend toward reduction of plasma glucose (Figure 7C). Although no 
significant changes were observed for serum concentrations of triglycerides (TG), 
total cholesterol (TC), and FFA (Figure 7D and 7E) between the two genotypes, 
the serum concentration of leptin was significantly reduced (Figure 7F) likely due 
to reduced WAT mass (Figure 1H). Adipose tissue energy homeostasis plays an 
important role in regulating fat deposition in non-adipose tissues such as liver. 
Overnutrition often induces hepatic steatosis. We found that inhibition of LD 
lipolysis in BAT reduced liver weight (Figure 7G) and hepatic contents of lipids, 
including triglycerides and cholesterol in HFD-fed mice (Figure 7H). Our results 




Brown adipocyte LD lipolysis is situated at the crossroad of cold-induced 
thermogenesis (Cannon and Nedergaard, 2004), but its in vivo significance has 
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not been examined in whole animals. In this study, we demonstrate that CGI-58-
dependent LD lipolysis in brown adipocytes is not essential for sustaining BAT 
UCP1 expression and for cold-induced thermogenesis in mice regardless of food 
availability. Instead, we show that mice with defective BAT lipolysis (BAT-KO 
mice) relative to control mice display higher body temperature when food is 
present during acute and chronic cold exposure. Inhibition of BAT lipolysis 
reprograms BAT to use more glucose and perhaps FFAs from the blood 
circulation and markedly enhances WAT browning. Our studies indicate that BAT 
LD lipolysis is not energetically critical in fueling thermogenesis, but plays a key 
role in regulating body’s multiple thermogenic mechanisms during cold 
adaptation.  
ATGL knockout mice are cold sensitive (Haemmerle et al., 2006), but the 
reason remains unclear given its severe cardiac phenotype. Mice lacking ATGL 
in both BAT and WAT are also cold sensitive (Ahmadian et al., 2011). These 
studies seem to suggest that adipose lipolysis is required for mice to defend 
against cold. However, Ahmadian et al. did not report cold sensitivity of their mice 
in the fed state. We found that mice lacking CGI-58 in both BAT and WAT (FAT-
KO mice) are cold sensitive only when food is not available. When food is left in 
the cage during cold exposure, FAT-KO mice are able to defend body 
temperature. Dr. Rudolf Zechner and associates had similar observations in their 
mice lacking ATGL in all adipose tissues (a manuscript recently submitted to Cell 
Metabolism). A recent human study using nicotinic acid, a pharmacological 
inhibitor of intracellular TG hydrolysis, shows that inhibition of intracellular TG 
- 53 - 
 
lipolysis in the whole-body abolishes cold-stimulated BAT thermogenesis, which 
is compensated by increased muscle shivering (Blondin et al., 2017). We did not 
measure muscle shivering in our mice due to technical challenges, but we 
acclimated our mice for a week to minimizing shivering prior to housing them at 
4oC for 7 days and we did not observe reduced thermogenesis during this 
chronic cold exposure (Figure 2) implying limited impact of muscle shivering on 
heat production in our animals. Nonetheless, it may be difficult to compare this 
short-term human study with studies using genetically altered animals because of 
its acute and broad nature of lipolysis inhibition. A previous study suggests a role 
of ATGL-mediated lipolysis of cytosolic LDs in UCP1 activation (Li et al., 2014). 
Although we did not directly measure UCP1 activation in CGI-58-deficient mature 
brown adipocytes, Dr. Zechner and associates compared the mitochondrial 
respiration (oxygen consumption) of tissue slices and mitochondria between 
ATGL-deficient BAT and control BAT, and did not observe any differences 
between the two genotypes (Schreiber’s manuscript submitted to Cell 
Metabolism). Additionally, both Dr. Zechner’s group and ours did not observe a 
significant reduction of iBAT UCP1 protein expression in lipolysis-deficient mice 
(i.e., mice lacking ATGL or CGI-58 in all adipose tissues) housed at room 
temperature. Mice lacking ATGL or CGI-58 in BAT only also did not show 
reduced iBAT UCP1 expression (Schreiber’s manuscript and Figure 3) under the 
adrenergic stimulation is attenuated in the iBAT of our HFD-fed BAT-KO mice 
(Figure 3), we estimate that the total UCP1 protein is increased in the CGI-5-
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deficient iBAT given that it has increased total amounts of proteins and DNAs 
(indicative of BAT recruitment). One explanation for attenuated responsiveness 
of UCP1 to cold or β3 agonist could be that UCP1 expression is already recruited 
to the highest level possible in the CGI-58-deficient BAT and there is no space 
for further upregulation. Increased sympathetic innervation to CGI-58-deficient 
BAT as evidenced by elevated expression of tyrosine hydroxylase (Figure 3D) 
and/or potentially augmented uptake of circulating FFAs via elevated CD36 
protein (Figure 4H) may contribute to maximal induction of UCP1 expression 
under this condition. Alternatively, the increased recruitment of beige adipocytes 
in the WAT of BAT-KO mice may reduce the need to upregulate UCP1 
expression in the classical BAT during cold exposure. Collectively, the findings 
from us and Dr. Zechner’s group suggest that lipolysis deficiency in adipose 
tissues does not impair thermogenic machinery in mice. Our comparative studies 
using BAT-KO and FAT-KO mice instead support a key role of WAT lipolysis in 
providing thermogenic substrates for cold adaptation during fasting. This 
conclusion is in total agreement with the finding from adipose ATGL knockout 
mice by Drs. Schreiber and Zechner (Schreiber’s manuscript).  
An interesting finding in this study is that BAT-KO mice display profound 
WAT browning. Mice with BAT paucity (Schulz et al., 2013) or hamsters with 
iBAT sympathetic denervation (Nguyen et al., 2016) also exhibit WAT browning, 
but this may be due to a general loss of BAT function or thermogenic stimulation. 
Here we show that selective inhibition of BAT lipolysis is sufficient to induce WAT 
browning suggesting a critical role of BAT lipolysis in whole-body 
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thermoregulation, though it is dispensable for cold-induced thermogenesis. It is 
currently unclear how this occurs at the molecular level and the origin of beige 
adipocytes. We observed that the protein level of tyrosine hydroxylase (TH), a 
marker of sympathetic innervation (Foster and Bartness, 2006), is elevated in 
both iBAT (Figure 3D) and inguinal fat (Figure 6E) suggesting a role of neural 
signals. BAT-derived adipokines (Batokines) are also critically implicated in BAT 
recruitment and WAT browning in response to cold exposure (Kajimura et al., 
2015; Wu et al., 2013). Future studies are needed to determine the origin of 
beige adipocytes in our mice and whether CGI-58-deficient BAT secretes more 
and specific browning batokines to directly stimulate WAT browning.  
Blondin et al. showed that nicotinic acid-induced inhibition of whole-body 
intracellular TG lipolysis reduced BAT uptake of 11C-acetate and 18F-
fluorodeoxyglucose tracers in cold-exposed humans (Blondin et al., 2017), which 
may not represent a direct effect of BAT lipolysis inhibition on its lipid and 
glucose uptake because other vital organs such as heart may compete with BAT 
to take up more of these tracers in the absence of intracellular lipolysis, 
particularly when WAT lipolysis is also inhibited and there is no enough to 
increase BAT mass (recruitment). We show in the present study that CGI-58-
deficient iBAT takes up more glucose. Although the underlying molecular 
mechanism remains to be delineated, CGI-58-deficient iBAT expresses 
increased mRNA for glucose transporter 1 (Glut1). Increased mRNA and protein 
expression of Glut1 was also observed in CGI-58-deficient muscle, macrophages 
and cultured cancer cells (Miao et al., 2014; Ou et al., 2014; Xie et al., 2015), and 
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thus may reflect a cell autonomous metabolic adaptation when energy stores in 
cytosolic LDs cannot be mobilized for utilization. While increased Glut1 mRNA 
seems to be inconsistent with unaltered glucose uptake per mg iBAT (wet 
weight) (Figure 4E), CGI-58-deficient iBAT shows a ~50% reduction in protein 
content per mg wet weight due to a ~2-fold increase in average cell size and TG 
content (Figure 1E and 1I). When normalized by iBAT protein content, glucose 
uptake is increased by ~2 fold in CGI-58-deficient iBAT. Considering iBAT as an 
organ, CGI-58-deficeint iBAT displays a 3-8-fold increase in wet weight 
depending on animal age, diet, and feeding duration. The increased wet weight 
of CGI-58-deficient iBAT can be fully accounted by steatotic hypertrophy and 
hyperplasia (indicative of BAT recruitment). Recruited BAT, together with 
recruited beige adipocytes, is expected to increase whole-body’s glucose 
disposal capacity during fasting, which may explain why a bolus of glucose only 
induces a modest rise in blood glucose in BAT-KO mice under cold (Figure 4C).  
CGI-58 deficiency in BAT seems to promote metabolic benefits as evidenced by 
improvement of glucose tolerance and decreases in plasma insulin, HOMA 
index, and hepatic steatosis after HFD feeding (Figure 7). It was reported that 
BAT critically regulates glucose homeostasis, insulin sensitivity and circulating 
lipids disposal (Bartelt et al., 2011; Stanford et al., 2013). A simple explanation is 
that more circulating nutrients, such as triglycerides, FFAs and glucose, are 
channeled to CGI-58-deficient BAT to produce heat, resulting in less nutrients 
flowing to other tissues including liver. Improved insulin sensitivity may also 
protect liver from steatosis as insulin-resistant liver shows augmented 
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lipogenesis (Brown and Goldstein, 2008). It was shown that BAT-derived 
neuregulin 4 protects liver against fat deposition by suppressing hepatic 
lipogenesis (Wang et al., 2014). It is possible that CGI-58-deficient BAT releases 
specific batokines to directly act on target tissues including liver, thereby 
preventing HFD-induced glucose intolerance and hepatic steatosis.  
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EXPERIMENTAL PROCEDURES  
Extended experimental procedures were included in the Supplemental Materials.  
Animals and Diets  
BAT-KO mice were produced by crossing CGI-58-floxed mice (Guo et al., 2013) 
with UCP1-Cre mice (Kong et al., 2014). FAT-KO mice were generated by 
crossing CGI-58-floxed mice with Adiponectin-Cre mice (Eguchi et al., 2011). 
Homozygous CGI-58 floxed mice without Cre transgene were as controls for all 
experiments. Mice housed at different temperatures were allowed 2-4 days of 
acclimation to different housing environment and temperatures. Mice were fed ad 
libitum a standard chow diet (LabDiet) or a HFD (D12492, Research Diets Inc.). 
Diet treatments and weight measurements were started at 6 weeks of age. All 
animal experiments were performed with male mice and approved by the 
Institutional Animal Care and Use Committees (IACUC) at the University of 
Maryland at College Park and at Georgia State University.  
Metabolic Phenotyping  
Indirect Calorimetry was used to measure energy expenditure, respiratory 
exchange ratio (RER), and physical activity. The core body temperature was 
continuously monitored by Telemetry. Rectal temperature was monitored using 
Thermalert TH-5 device (Physitemp). Food intake was measured in metabolic 
chambers. Body composition was determined by using by EchoMRI-100H Body 
Composition Analyzer (EchoMRI LLC.).  
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Lipase Activity Assays  
Tissue lipase activity was assayed as described previously (Wei et al., 2007).  
In vivo Lipolysis Assays  
The mice were injected intraperitoneally with isoproterenol and plasma 
concentrations of FFAs and glycerol analyzed using commercial available kits.  
Immunohistochemistry, Glucose and Insulin Tolerance Tests, Glucose 
Uptake Assays, Tissue Lipid Analyses, Immunoblotting  
These standard procedures were described in details in the Supplemental 
Materials.  
Analyses of Adipocyte Size  
The adipose tissue cell sizing was done in osmium-fixed urea-isolated adipocytes 
as described previously (Etherton et al., 1977).  
Statistical Analysis  
Data are expressed as Mean ± SEM, and were tested for statistical significance 
by Two-way ANOVA with Bonferroni post hoc tests when both genotypes and 
treatments were considered, or by Student t-tests when the two genotypes were 
compared. The p value less than 0.05 was considered statistically significant. 
Data were analyzed using Grad Pad software and SAS version 9.2 (SAS 
Institute, Inc.). For all Figures, *p < 0.05 and **p < 0.01 vs. genotype on the same 
diet; #p < 0.05 vs. treatment of the same genotype.  
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Legends to Figures  
Figure 1. CGI-58 Deletion in BAT Causes iBAT Steatosis, Hypertrophy and 
Hyperplasia (A) Weight gain of 6-week-old (Week 0) BAT-KO (KO) and control 
(Con) mice subjected to chow (n = 10/group) or HFD (n = 11/group).  
(B) Food intake of mice on the fifth week of chow (n = 6/group) or HFD (n = 
11/group).  
(C) Gross appearance of iBATs in 24-week-old mice on chow diet.  
(D) H&E staining of iBATs from 14-week-old chow-fed mice.  
(E) Average brown adipocyte sizes in iBATs of mice on HFD for 18 weeks. For 
each mouse, 5,000 cells were measured. n = 5/group.  
(F, G) Relative DNA and protein amounts of whole iBAT in 14-week-old mice on 
chow. n = 5/group.  
(H) Adipose depot/body weight ratios (%) of mice on HFD for 5 weeks. n 
=7/group.  
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(I) TG content in individual adipose depots of mice on HFD for 18 weeks. n = 5-
7/group.  
(J) Lipase activity of iBATs from 14-week-old chow-fed mice. n = 5/group.  
(K) In vivo lipolysis capacity of mice on HFD for 4 weeks. n = 5/group.  
Figure 2. Mice Lacking CGI-58 in UCP1-Positive Cells Are Not Cold 
Sensitive  
(A) Rectal temperatures of 20-week-old HFD-fed BAT-KO (KO) and control (Con) 
mice at 22oC. n = 4-5/group.  
(B, C) Rectal temperatures of 10-11-week-old chow-fed mice exposed 4oC in the 
absence or presence of diet. n = 5/group.  
(D) Core body temperatures of 28-week-old HFD-fed mice exposed to 4oC in the 
absence of food. n = 5-6/group.  
(E) Core body temperatures of 24-week-old HFD-fed mice exposed to 4oC in the 
presence of food. n = 5-6/group. (F) Core body temperatures of 18-week-old 
HFD-fed mice during 7 days of cold exposure. n = 6/group.  
Figure 3. UCP1 Expression Is Not Reduced in CGI-58-Deficient iBAT  
(A) Western blots and densitometry of iBAT UCP1 protein in 14-week-old chow-
fed mice.  
(B) Relative iBAT expression levels of thermogenesis-related genes from the 
mice injected with CL-316,243 for 4 days (CL) or vehicle (Saline). n = 5/group.  
(C) Western blots and densitometry of iBAT UCP1 in the same mice described 
under 3B.  
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(D) Western blots and densitometry analyses of iBAT UCP1 and TH proteins in 
18-week-old HFD-fed mice at 22oC (Basal) or 4oC for 7 days (Cold).  
(E) iBAT mRNA levels in the mice described under 3D. n = 4-5/group.  
Figure 4. BAT-KO Mice Show Increased Capacity to Use Circulating 
Substrates for Heat Generation  
(A and B) Average daily calorie intake (A) and respiratory exchange ratio (RER) 
(B) of 18-week-old HFD-fed BAT-KO (KO) and control (Con) mice during 7 days 
of cold exposure. n = 5-6/group.  
(C and D) Blood glucose levels (C) and body temperature (D) changes of 12-
week-old HFD-fed mice after a bolus of glucose injection (i.p., at 1.5 g/kg body 
weight). The mice were fasted for 7h (4h at room temperature and 3h at cold) 
prior to glucose injection. n = 4-5/group.  
(E) Tissue glucose uptake in 20-week-old HFD-fed mice during acute cold 
exposure. The total glucose uptake of iBAT was calculated based on the total 
iBAT weight. n = 4-5/group.  
(F) iBAT mRNAs for glucose transporter 1 (Glut1) and glucose transporter 4 
(Glut4) in mice at 22oC (Basal) or 4oC for 7 days (Cold). n = 5/group.  
(G) iBAT mRNAs for CD36, lipoprotein lipase (LPL), fatty acid transporter protein 
1 (FATP1) in 14-week-old HFD-fed mice at 22oC. n = 5/group.  
(G) Immunoblots and densitometry analyses of iBAT CD36 protein in mice 
exposed to cold for 7 days or injected daily with CL-316,243 for 4 days.  
Figure 5. Lipolysis-Deficient FAT-KO Mice Are Not Cold Sensitive When 
Food Is Available  
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(A) Weight gain of FAT-KO and Control mice on chow (n = 9-12) or HFD (n = 10-
13. Mice were 6 weeks old at Week 0.  
(B) Calorie intake on the fifth week of chow (n = 5-6/group) or HFD (n = 5-
6/group) treatment.  
(C) Body composition of 12-week-old HFD-fed mice. n = 6/group.  
(D) Adipose depot/body weight ratios in 24-week-old HFD-fed mice. n = 7/group.  
(E) Gross appearance of iBATs from 24-week-old HFD-fed mice.  
(F) H&E staining of iBATs from 14-week-old HFD-fed mice.  
(G) Adipocyte size of iBATs from 24-week-old HFD-fed mice. For each sample, 
5,000 cells were measured. n = 5/group.  
(H) In vivo lipolysis capacity of 10-week-old HFD-fed mice.  
(I) Core body temperatures of 26-week-old HFD-fed mice during cold exposure in 
the absence of food. n = 5-6/group.  
(J) Core body temperatures of 23-week-old HFD-fed mice during cold exposure 
in the presence of food. n = 5-6/group.  
(K) Western blots and densitometry of iBAT UCP1 protein in 22-week-old HFD-
fed mice.  
(L) iBAT UCP1 mRNA levels in 22-week-old HFD-fed mice. n = 4/group.  
Figure 6. CGI-58 Deletion in BAT Enhances WAT Browning  
(A) H&E staining of iWATs from 14-week-old chow-fed BAT-KO (KO) and control 
(Con) mice (top), 18-week-old HFD-fed mice (middle), and 18-week-old HFD-fed 
mice exposed to cold for 7 days (bottom).  
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(B) Immunohistochemical staining of iWAT UCP1 protein in 18-week-old HFD-fed 
mice or 18-week-old HFD-fed mice exposed to cold for 7 days.  
(C, D) iWAT UCP1 mRNA (C) and protein (D) levels in 18-week-old HFD-fed 
mice at 22oC (B) or 4oC for 7 days (C) (n = 4-5/group), or 14-week-old HFD-fed 
mice injected with CL-316,243 for 4 days (CL) or saline (S) (n = 5/group).  
(E) Western blots and densitometry of iWAT tyrosine hydroxylase (TH) in 18-
week-old HFD-fed mice exposed to cold for 7 days.  
Figure 7. CGI-58 Deletion in BAT Improves Metabolic Profiles in Mice on 
HFD  
(A) Glucose tolerance test (GTT) and insulin tolerance test (ITT) in BAT-KO (KO) 
and control (Con) mice on HFD. n = 9-11/group.  
(B) HOMA-insulin resistance (IR) index in overnight-fasted 17-week-old HFD-fed 
mice. n = 6/group.  
(C) Plasma concentrations of insulin and glucose in 17-week-old HFD-fed mice 
fasted overnight. n = 6/group.  
(D and E) Serum concentrations of triglycerides (TG) and total cholesterol (TC) in 
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Supplemental Figures and Figure Legends 
 
Figure S1. Effects of BAT CGI-58 Deficiency on iBAT DNA and Protein 
Contents, Body Composition and Metabolic Phenotypes (linked to Figure 1) 
(A) Immunoblots of CGI-58 in adipose depots and other tissues of 24-week-old 
HFD-fed BAT-KO (KO) and control (Con) mice. GAPDH was used as a loading 
control. Quad., quadriceps; Gas., gastrocnemius. 
(B, C) DNA and protein contents of the iBAT from 14-week-old mice on chow. n = 
5/group. 
(D) Fat and lean body mass of mice on HFD for 9 weeks. n = 6/group.  
(E) Metabolic phenotypes of 23-week-old HFD-fed BAT-KO (KO) and control 
(Con) mice housed at room temperature (22oC) or thermoneutrality (30oC). n = 
6/group. *p < 0.05 vs. genotype; #p < 0.05 vs. temperature treatment of the same 
genotype.




Figure S2. Mice Lacking CGI-58 in UCP1-Positive Cells Display Increased 
Energy Expenditure During Chronic Cold Exposure (linked to Figure 2) 
(A) Total energy expenditure (TEE) of 28-week-old HFD-fed BAT-KO (KO) and 
control (Con) mice during acute cold without food, of 24-week-old HFD-fed mice 
during acute cold with food, and of 18-week-old HFD-fed mice during 7 days of 
cold exposure. n = 5-6/group.  
(B) Total physical activity of 18-week-old HFD-fed mice during 7 days of cold 
exposure. n = 5-6/group. 
*p < 0.05 and **p <0.01 vs. genotype.  
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Figure S3 (linked to Figure 4). Insulin-stimulated glucose uptake in the adipose 
and muscle tissues of 29-week-old HFD-fed BAT-KO (KO) and control (Con) 
mice. n = 5-6/group.  
 




Figure S4. Adipose-Specific Deletion of CGI-58 in FAT-KO Mice (linked to 
Figure 5) 
(A) Immunoblots of CGI-58 protein in tissues from FAT-KO and control mice. 
GAPDH was used as a loading control. Gas., gastrocnemius. 
(B) DNA and protein amounts and contents of the iBATs from 14-week-old mice 
on chow. n = 5/group. 
(C) Immunoblots of UCP1 protein in the iBATs of 14-week-old chow-fed mice. 
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Objective 2.  
Rationale 
In Objective 1, we mainly focused on the role of BAT lipolysis in cold-induced 
thermogenesis. In contrast to our working hypothesis, BAT-KO mice showed 
normal to higher body temperature during cold exposure. The lipolysis-deficient 
BAT as an organ had normal UCP1 expression, increased sympathetic 
innervation, and elevated glucose uptake and CD36 expression. In addition, 
selective ablation of CGI-58 in BAT increased the sympathetic innervation in 
iWAT resulting in increased recruitment of beige adipoctyes. Therefore, we 
concluded in Objective 1 that BAT lipolysis is not required for whole-body 
thermoregulation, but has a critical role in activation of compensatory 
thermogenic mechanisms such as BAT uptake of thermogenic substrates and 
WAT browning. In Objective 2, our goal was to identify the role of WAT lipolysis 
in cold-induced thermogenesis and metabolic health. Given that there are no 
genetic manipulations specific for WAT, we employed an indirect approach to 
achieve our goal. We characterized mice lacking CGI-58 in both BAT and WAT 
(FAT-KO mice). We reasoned that comparison of phenotypes from FAT-KO mice 
with those from the mice lacking CGI-58 in BAT only (BAT-KO mice) would 
reveal some effects specific for WAT lipolysis.  
 
Fat-Specific CGI-58 Deletion Abolishes Adipose Lipolysis 
We have shown under Objective 1 that FAT-KO mice have increased fat mass 
and adipose depot weights (Figure 1C and 1D of Objective 1). Morphological 
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examinations of iWAT by H&E staining showed that white adipoctyes in the iWAT 
of FAT-KO mice were enlarged (Figure 6A). The average diameter of iWAT white 
adipoctyes in FAT-KO mice was increased, and the population of enlarged 
adipocytes was also increased (Figure 6B), which likely resulted from inhibition of 
CGI-58-mediated lipolysis (see Objective 1). Consistently, ex vivo lipolysis 
assays showed that iWAT explants had an impaired response to a β-adrenergic 
agonist in glycerol release (Figure 6C). 
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Figure 6. Inactivation of CGI-58 in Adipose Tissues Causes WAT 
Hypertrophy and Abolishment of Lipolysis Stimulated by an Adrenergic 
Receptor Agonist.  
(A) H&E staining of the iWAT from 18-week-old HFD-fed control and FAT-KO 
mice.  
(B) Average white adipocyte sizes in iWAT of mice on HFD for 18 weeks. For 
each mouse, 5,000 cells were measured (left panel) and categorized into 
different size group (right panel).  
(C) Ex vivo lipolysis of iWAT from 14-week-old chow-fed mice. Glycerol release 
into tissue culture media was measured after a 2h incubation at 37
o
C in the 
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absence (Basal) or presence of isoproterenol (Iso). n = 5 per group. *p < 0.05 vs. 
genotype; #p < 0.05 vs. treatment. 
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Fat-Specific Deletion of CGI-58 Down-regualtes Whole-Body Thermogenic 
Capacity  
In Objective 1, we have shown that FAT-KO mice on HFD are cold sensitive only 
when food is not available during cold exposure (Figure 5J in Objective 1). 
Similar results were obtained when the rectal temperature was measured during 
acute cold exposure in mice on chow or HFD (Figure 7).  
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Figure 7. FAT-KO Mice on Chow or HFD Are Not Cold Sensitive When Food 
Is Available During Cold Exposure.  
(A,B) Cold-induced rectal temperature changes of 10-week-old chow-fed mice in 
the absence of food (A), or 11-week-old chow-fed mice in the presence of food 
(B). n = 4-6.  
(C) Cold-induced rectal temperature changes of 11-week-old HFD-fed mice in the 
absence of food (C), or 12-week-old HFD-fed mice in the presence of food. n = 4-
6.  
*p < 0.05, **p < 0.01 vs. genotype. 
 
- 90 - 
 
 To determine if CGI-58 deletion in whole-body fat affects whole-body 
energy balance and body temperature under different environmental conditions, 
we performed metabolic phenotyping using Indirect Calorimetry and Telemetry 
(Figure 8). FAT-KO mice displayed no significant changes in TEE, core body 
temperature, RER, food intake, and total activity when housed at either room or 
thermoneutral temperature, though their oxygen consumption waslower at room 
temperature (Figure 8A-F). To measure the capacity of NST, we administered 
thermoneutrally housed mice with CL-316,243 at 0.1 kg/body weight (Figure 8G-
H). FAT-KO mice showed blunted responses to the β-adrenergic agonist 
stimulation in heat production (Figure 8G), oxygen consumption (Figure 8H), and 
RER reduction (Figure 8I).  
 





Figure 8. Mice Lacking Adipose Lipolysis Are Resistant to β-Adrenergic 
Agonist-Induced Increases in Body Temperature and Oxygen Consumption.  
(A-F) Metabolic phenotypes of 22-week-old HFD-fed FAT-KO and control mice 
housed at room temperature (22 
o
C) or thermoneutrality (30 
o
C).  
(G-I) Core body temperature changes (G), oxygen consumption (H), and 
Respiratory Exchange Ratio (RER) (I) in 22-week-old HFD-fed FAT-KO and 
control mice before and after CL-316,243 injections at thermoneutrality (30 
o
C). n 
= 5-6/group.  
*p < 0.05, **p<0.01 vs. genotype; #p < 0.05 vs. temperature treatment. 
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 To determine how FAT-KO mice respond to cold in energy metabolism, 
we performed metabolic phenotyping during cold exposure. It was found that 
FAT-KO mice relative to controls displayed higher RER during cold exposure and 
this higher RER level stayed longer when food was present than absent (Figure 
9A and 9B). Cold-exposed FAT-KO mice showed reduced TEE only in the 
absence of food and no changes in physical activities (Figure 9C and 9D).  
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Figure 9. FAT-KO Mice Display Increased Glucose Utilization During Cold 
Exposure and Reduced Energy Expenditure Only When Food Was Absent 
During Cold Exposure.  
(A) Cold-induced changes of RER in 26-week-old HFD-fed mice in the absence 
of food. 
(B) Cold-induced RER changes in 23-week-old HFD-fed mice in the presence of 
food.  
(C) Total energy expenditure and total activity of the cold-exposed mice 
described above in the absence of food.  
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(D) Total energy expenditure and total activity of the cold-exposed mice 
described above in the presence of food.  
n = 5/group; *p < 0.05, **p < 0.01 vs. genotype; #p < 0.05 vs. temperature 
treatment. 
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FAT-KO Mice Are Resistant to β-Adrenergic Agonist-Induced Increases of 
UCP1 Expression in iBAT 
To examine whether the thermogenic machinery of lipolysis-deficient BAT 
respond normally to activation of β3-adrenergic receptor, we treated FAT-KO and 
control mice with CL-316,243 (1 mg/kg body weight once daily for 4 days), and 
measured protein and mRNA levels of genes relevant to thermogenesis in the 
iBAT (Figure 10). While UCP1 protein and mRNA levels were not significantly 
different between the two genotypes under the saline-injected (basal) condition, 
they were not increased in FAT-KO mice as the controls did in response to CL-
316,243 injections (Figure 10A-C). Dio2 and PGC1-α, two genes implicated in 
BAT thermogenesis, were significantly increased in FAT-KO mice under the 
basal conditions, though these increases were attenuated after CL-316-243 
stimulation (Figure 10C). Considering a dramatic increase in iBAT hyperplasia 
(see Objective 1), the total amounts of UCP1, Dio2 and PGC-1α in the iBAT were 
actually increased or at lest stayed unchanged. Thus, lipolysis-deficient BAT has 
intact thermogenic machinery, at least in vivo. While this BAT cannot mobilize 
cytosolic LDs as thermogenic fuels, it has increased expression of glucose 
transporter 1 (Glut1) that mediates a cell’s basal glucose uptake, as well as 
CD36 that mediates FFA uptake (Figure 10C), implying that lipolysis-deficient 
BAT may use more circulating fuels.   
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Figure 10. Mice Lacking Adipose Lipolysis Are Resistant to β-Adrenergic 
Agonist-Induced Increases of UCP1 Expression in iBAT. 
(A) iBAT UCP1 and CD36 protein expression and densitometry of 14-week-old 
HFD-fed mice housed at room temperature and treated with or without the β–
adrenergic agonist CL-316,243 for 4 days.  
(B) iBAT UCP1 protein expression and densitometry of 14-week-old chow-fed 
mice housed at room temperature.  
(C) mRNA expression levels in the iBAT of 14-week-old HFD-fed mice 
administered consecutively with vehicle (Saline) or CL-316,243 for 4 days.  
n = 5/group; *p < 0.05 vs. genotype; #p < 0.05 vs. temperature treatment.  
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Mice Deficient in Adipose Lipolysis Utilize More Glucose as a Thermogenic 
Substrate During Cold Exposure 
To test whether FAT-KO mice uses more glucose for thermogenesis during cold 
exposure, we measured blood glucose levels of the mice exposed to cold and 
adminitrated with a bolus of glucose. Consitently with increased glucose 
utilization in FAT-KO mice during cold exposure, a bolus of glucose injection 
cannot raise blood glucose levels in these animals as it did in the controls (Figure 
11A). Although the body temperature of FAT-KO mice was still lower than the 
controls after glucose injection, it was higher than FAT-KO mice without glucose 
(Figure 11B), implying that glucose was used for heat produtction. To identify 
tissues with increased glucose use during cold exposure, we measured tissue 
glucose uptake during acute cold exposure without insulin administration. 
Strikingly, there was a ~12-fold increase of cardiac glucose uptake in FAT-KO 
mice versus controls (Figure 11C). Although iBAT glucose uptake was 
significantly reduced when expressed as glucose uptake per mg wet tissue, BAT 
from FAT-KO mice showed significantly increased glucose uptake as an organ 
(Figure 11D) due to the increased iBAT weight (see Objective 1).  
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Figure 11. Mice Lacking Adipose Lipolysis Are Resistant to Glucose-
Induced Increases in Blood Glucose During Cold Exposure and Display a 
Dramatically Increased Glucose Uptake in the Heart and the iBAT as an 
Organ.  
(A) Blood glucose levels of 11-week-old HFD-fed mice during acute cold 
exposure 60 min before and 180 min after a bolus of glucose (i.p., at 1.5 g/kg 
body weight). n = 4 - 5/group.  
(B) Body temperature changes in the mice described in (A). Reference body 
temperature without glucose injection is from Figure 7C.  
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(C) Tissue glucose uptake in 20-week-old HFD-fed mice during acute cold 
exposure.  
(D) Glucose uptake of whole iBAT. n = 4 - 5/group.  
*p < 0.05, **p < 0.01 vs. genotype. 
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Although Glut4 mRNA levels remain unaltered in the iBAT of FAT-KO 
mice (Figure 10C), insulin stimulates Glut4 protein translocation from intraceuular 
compartments to the cell surface to mediate glucose uptake in the fed state. To 
examine whether lipolysis-deficient BAT has increased glucose uptake in the fed 
state, we measured insulin-stimulated glucose uptake in FAT-KO mice. It was 
found that iBAT glucose uptake under this condition was reduced when 
normalized by mg wet weight (Figure 12A) and only slightly increased when 
normalized by the total iBAT weight (not shown). Interestingly, while epididymal 
fat glucose uptake was reduced, there was a significant increase in  insulin-
stimulated glucose uptake in the gastrocnemius muscle and heart of FAT-KO 
mice (Figure 12A).  
Normally, heart uses FFAs as fuels. When it is forced to use more glucose 
due to lipolysis deficiency, its functions are likely changed due to glucose-
induced cardiac remodeling. Indeed, the mRNAs for BNP and ANP, two cardiac 
hormones sensitive to cardiac functional alterations, especially heart failure, were 
significantly increased in the heart of FAT-KO mice (Figure 12B). 





Figure 12. Insulin-Induced Glucose Uptake Is Dramatically Increased in the 
Heart of FAT-KO Mice. 
(A) Tissue glucose uptake induced by insulin in 28-week-old HFD-fed mice 
housed at room temperature. n = 5 - 6/group.  
(B) ANP and BNP mRNA expression levels in the hearts of 14-week-old HFD-fed 
mice housed at room temperature. n = 4 - 5/group.  
*p < 0.05, **p < 0.01 vs. genotype. 
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β3-Adrenergic Stimulation Cannot, But Cold Can Induces WAT Browning in 
FAT-KO Mice 
We have shown in BAT-KO mice that BAT lipolysis deficiency induces WAT 
browning (Figure 6 of Objective 1). To test if this is WAT lipolysis-dependent, we 
first stimulated iWAT browning using CL-316,243. As expected, the adipocyte 
size in the iWAT was reduced in the control mice after CL-316-243 stimulation 
(Figure 13A), which was associated with increased mRNAs for UCP1, PGC-1, 
and PPAR- (Figure 13B) as well as increased UCP1 protein expression as 
evidenced by immunohistochemistry (Figure 13C) and immunoblotting (Figure 
13D). These changes did not happen or even suppressed after β3-adrenergic 
stimulation (Figure 13A-D).  




Figure 13. Mice Deficient in Adipose Lipolysis Are Resistant to β3-
Adrenergic Agonist-Induced Increases of UCP1 Expression in iWAT.  
(A) Representative H&E staining of iWAT.  
(B) mRNA levels of UCP1, PGC-1 and PPAR- in the iWAT. n = 5/group.  
(C) Immunohistochemical staining of UCP1 protein in the iWAT. 
(D) Immunoblotting of UCP1 protein in the iWAT.  
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All experiments were done with the 14-week-old HFD-fed mice injected 
consecutively with vehicle (Saline) or CL-316,243 for 4 days. *p < 0.05 vs. 
genotype; #p < 0.05 vs. CL treatment. 
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To determine whether FAT-KO mice respond to cold similarly in terms of 
WAT browning, we exposed our mice to cold for 3 days after a 7 day acclimation 
period. Interestingly, adipose lipolysis deficiency did not impair cold-induced 
increases of UCP1 protein expression (indicative of increased iWAT browning) 
(Figure 14A and 14B), though it did to the β3-adrenergic receptor stimulation-
induced WAT browning. In addition to UCP1, TH (a marker of sympathetic 
innervation) was also similarly increased in the two genotypes during cold 
exposure (Figure 14A and 14B).  





Figure 14. Adipocyte Lipolysis Deficiency Does Not Affect Cold-Induced 
iWAT Browning.   
(A) Immunoblotting of TH and UCP1 protein in the iWAT 
(B and C)  Densitometry of TH and UCP1 protein in the iWAT 
All experiments were done with the 22-week-old HFD-fed mice with basal or 3 
days of cold. *p < 0.05 vs. genotype; #p < 0.05 vs. Cold treatment. 
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Metabolic Benefits of CGI-58 Deletion in Fat.  
Under Objective 1, we have seen several metabolic benefits of BAT lipolysis 
suppression in mice on an HFD (Figure 7 of Objective 1). We hypothesized that 
these benefits may be amplified due to simultaneous inhibition of lipolysis in both 
BAT and WAT. Indeed, adipose lipolysis deficiency induced by fat-specific 
inactivation largely protected mice against HFD-induced glucose intolerance and 
insulin resistance (Figure 15A). HOMA-IR index was also reduced in FAT-KO 
mice, though it did not reach statistical significance due to large variations of the 
values (Figure 15B). Serum levels of leptin were unaffected in FAT-KO mice 
(Figure 15C), though fat mass was increased (see Objective 1). As expected, 
fasting failed to raise serum FFAs due to lipolysis inhibition in FAT-KO mice 
(Figure 15D). Interestingly, FAT-KO mice displayed a significant reduction in 
serum TG levels during fasting, but not in the fed state (Figure 15E). No changes 
in serum total cholesterol (TC) were observed in FAT-KO mice in both fed and 
fasted states (Figure 15E). In addition, liver weight was significantly lower due to 
reduced accumulation of TG in the liver of FAT-KO mice (Figure 15F). Hepatic 
contents of free cholesterol (FC) and total cholesterol (TC) did not differ between 
the two genotypes (Figure 15F), suggesting that FAT-KO mice on HFD are 
protected from developing hepatic steatosis. Collectively, the results 
demonstrated that suppression of fat lipolysis improves metabolic health in mice 
presumably by preventing FFA overloads and by improving glucose disposal.  









Figure 15. Mice Deficient in Adipose Lipolysis Exhibit Increased Glucose 
Tolerance and Insulin Sensitivity and Are Protected Against HFD-Induced 
Hepatic Steatosis.  
(A) GTT and ITT of the mice on chow for 16 or 17 weeks or HFD for 16 or 17 
weeks. n = 5 - 6/group in chow-fed mice; n = 7 - 8/group in HFD-fed mice.  
(B) Fasting plasma levels of insulin and glucose as well as HOMA-IR in 17-week-
old HFD-fed mice. n = 5 - 6/group.  
(C) Serum leptin levels of 15-week-old HFD-fed mice in the fed state. n = 5 - 
6/group.  
(D) Serum FFA levels of 15-week-old HFD-fed mice in the fed and of 17-week-old 
HFD-fed mice in the fasted state. n = 5 - 6/group.  
(E) Serum levels of triglycerides (TG) and total cholesterol (TC). n = 5 - 6/group.  
(F) Liver-to-body weight ratios of 24-week-old mice on chow or HFD as well as 
hepatic contents of free cholesterol (FC), TC and TG in 24-week-old HFD-fed 
mice. n = 5/group.  
*p < 0.05, **p <0.01 vs. genotype; #p < 0.05 vs. fed or fasted state.  
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 Discussion 
The major findings with FAT-KO mice are 1) adipose lipolysis is required for cold-
induced thermogenesis only during fasting; 2) In the fed state, dietary nutrients 
can substitute for adipose lipolysis deficiency to maintain cold-induced 
thermogenesis, at least for a few days in mice; 3) Mice deficient in adipose 
lipolysis utilize more circulating glucose, especially during cold exposure; 4) Mice 
deficient in adipose lipolysis are protected against overnutrition-induced glucose 
intolerance and insulin resistance; and 5) Adipose lipolysis deficiency likely 
impairs cardiac functions by forcing the heart to use more glucose for oxidation 
driving cardiac remodeling.  
It has been reported that cold stimulates BAT to use glucose for 
thermogenesis in addition to FFAs in both insulin-dependent and independent 
manners [210, 223-228]. Our findings with FAT-KO mice indicate that cold-
induced glucose utilization is further upregulated in the absence of adipose 
lipolysis. Although the underlying mechanisms may reflect an integrated whole-
body response that may involve altered secretion of batokines and activation of 
the sympathetic nervous system [229, 230], the cell autonomous adaptation may 
also play a part. We have previously shown in cultured cells that CGI-58 
deficiency promotes glucose uptake [154, 231, 232]. Thus, cells may program its 
metabolism to take up more exogenous fuels when cytosolic LD cannot be 
mobilized for use as substrates. It is currently unclear whether glucose in 
lipolysis-deficient BAT is used directly or after conversion to FFAs via de novo 
lipogenesis for heat production.  
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Based on RER (indicative of substrate preference) and body temperature 
changes during chronic cold exposure, glucose-mediated thermogenesis may not 
be sustainable. Lipolysis-deficient BAT showed increased CD36 protein 
expression after chronic CL-316,243 treatment or cold exposure. CD36 has been 
implicated in FFA uptake from the circulation [214] and upregulation of HSL-
mediated LD lipolysis activity [233] in adipocytes. In addition, the BAT of CD36-
null mice had blunted glucose uptake during cold exposure [208], suggesting that 
there is a CD36-dependent crosstalk between FFA and glucose utilization in BAT. 
Increased BAT CD36 expression in both BAT-KO and FAT-KO mice after chronic 
cold or CL-316,243 treatment could provide more sustainable thermogenic fuels 
for BAT to combust in the absence of lipolysis.  
In addition to increasing BAT uptake of thermogenic substrates, beige 
adipocyte attainment in iWAT (iWAT browning) is another compensatory 
mechanism for BAT lipolysis-deficient mice to boost whole-body thermogenic 
capacity in BAT-KO mice (Objective 1). Beige adipocytes, like brown adipocytes, 
may combust FFAs and glucose. It seems that the glucose uptake in beige 
adipocytes is insulin-independent, largely relying on Glut1 [234]. We observed 
that the β3 agonist CL-316,243-induced iWAT browning is WAT lipolysis-
dependent because it occurs only in BAT-KO mice, but not in FAT-KO mice. 
Interestingly, the iWAT of FAT-KO mice can be browned to the same extent as 
the control mice in response to the cold as evidenced by increased UCP1 
expression (Figure 14). Expression of TH protein, a marker of sympathetic 
innervation, was also increased in the iWAT of FAT-KO mice after cold exposure 
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(Figure 14). Although β3 is the predominant form of β-adrenergic receptors in 
WAT [81] and its activation by CL-316-243 does not increase UCP1 expression 
in the iWAT of FAT-KO mice, the increased sympathetic innervation may activate 
other forms of β-adrenergic receptors to promote thermogenesis, or simply reflect 
an augmented response to the cold on the face of adipose lipolysis deficiency, 
which may not lead to activation of downstream receptors. Alternatively cold may 
have triggered other browning mechanisms in addition to the sympathetic activity, 
which may result in iWAT browning.  
One potential β3-adrenoceptor-independent thermogenic mechanisms 
noted in our study is ANP and BNP whose expression levels are significantly 
increased the heart of FAT-KO mice. This increase in ANP and BNP could result 
from increased glucose uptake. It has been shown that heart-specific 
overexpression of Glut1 in mice results in contractile dysfunction due to 
increased oxidative stress [235]. In general, ANP and BNP are elevated in heart 
as a result of failed natriuretic and vasodilating actions [236]. As mentioned in the 
Introduction section, ANP and BNP can activate thermogenesis via cAMP-
independent but p38 MAPK-dependent signaling in iWAT [237, 238]. It is 
tempting to speculate that FAT-KO mice may release increased amounts of ANP 
and BNP during chronic cold exposure as a result of increased cardiac glucose 
uptake, thereby inducing iWAT browning. Future studies are warranted to 
investigate how adipose lipolysis deficiency alters cardiac functions and how this 
alteration regulates metabolism and pathophysiology of other organs via ANP 
and BNP in FAT-KO mice. 
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BAT glucose uptake is reduced in humans and mice when adipose 
lipolysis is inhibited by niacin [228, 239]. This might be a result of re-distribution 
of glucose uptake when adipose lipolysis is deficient as seen in our FAT-KO mice 
when glucose uptake is expressed as mg BAT wet weight. When lipolysis is 
selectively inactivated in the BAT of our BAT-KO mice, the total glucose uptake 
by BAT as an organ is increased after insulin stimulation and during acute cold 
exposure. Interestingly, glucose uptake is increased in heart and gastrocnemius 
muscle of FAT-KO but not BAT-KO mice. In humans treated with niacin, cold 
induces shivering [228, 239]. Shivering thermogenesis can compensate for 
impaired NST for heat production to maintain body temperature. For example, 
UCP1 KO mice are deficient in NST, but can tolerate cold via shivering after cold 
acclimation [240]. Therefore, it is important to assess NST in mice [241], which 
can be done by housing mice under a thermoneutral temperature (30 oC), 
followed by injection of NE [241-243]. We observed that FAT-KO, but not BAT-
KO mice at thermoneutrality have reduced NST capacity after CL-316,243 
injection (see Figure 8 for FAT-KO mice; data not shown for BAT-KO mice), 
suggesting a critical role of WAT lipolysis in sustaining NST. Consistently, 
oxygen consumption in primary brown adipocytes from UCP1 knockout mice is 
normal when the cell culture medium has FFAs, and is suppressed when FFAs 
are removed from in the culture medium by a high concentration of BSA [244]. In 
addition, the effect of NE on metabolic rates is enhanced following food intake 
[245]. Our BAT-KO and FAT-KO mice display higher body temperature when 
food is present than absent during acute cold exposure. Collectively, our results 
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together with published data indicate that white adipocyte lipolysis and dietary 
substrates are essential for NST in the absence of brown adipocyte lipolysis.  
While adipose lipolysis deficiency impairs cold adaptation during fasting 
and may influence cardiac functions, it protects against overnutrition-induced 
metabolic disorders including glucose intolerance, insulin resistance and hepatic 
steatosis. This protection may be mediated by increased disposal of glucose for 
fueling the heart and thermogenesis when adipose lipolysis is deficient. 
Alternatively, lipolysis deficiency may promote secretion of insulin-sensitizing 
factors, which may regulate locally and remotely insulin signaling, energy 
balance and lipid metabolism. 
 
Summary 
It was believed that lipolysis of cytosolic LDs in brown adipocytes plays a central 
role in NST, but this concept has not been examined in vivo in whole animals due 
to lack of appropriate animal models. In this project, we have filled this gap in the 
field using mice with lipolysis deficiency in BAT only and those with lipolysis 
deficiency in both BAT and WAT. We demonstrate that brown adipocyte LD 
lipolysis is not essential for cold-induced thermogenesis in vivo due perhaps to 
enhanced WAT browning and increased uptake of circulating thermogenic fuels 
that are derived from WAT lipolysis and diet. Comparative studies with mice 
deficient in CGI-58, an intracellular lipolysis activator, in different fat depots (BAT 
or both BAT and WAT) uncover a critical role of WAT lipolysis in cold-induced 
thermogenesis during fasting. In the fed state, dietary nutrients can substitute for 
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WAT lipolysis for thermogenesis, at least for a short period. A proposed model 
for thermoregulation in mice deficient in lipolysis in brown and/or white 
adipocytes is summarized in Figure 16.  
 A limitation of our approach is that it did not provide direct evidence as to 
the role of WAT lipolysis in thermoregulation. Although there are currently no 
WAT-specific genetic manipulations, we could, in the future, create a BAT-
specific CGI-58 transgenic mice and then cross them with our FAT-KO mice. 
This way, we will have mice deficient in lipolysis in WAT only. We could then 
define how WAT lipolysis influences thermogenesis and metabolic health.  
While our study has clarified the in vivo significance of adipocyte cytosolic 
LD lipolysis in thermoregulation, it raises many intriguing questions. What is the 
molecular mechanism sensing brown adipocyte lipolysis deficiency? How does 
this mechanism communicates with other metabolic and cellular and pathways to 
regulate thermogenesis? Is the sympathetic innervation necessary for WAT 
browning when adipose lipolysis is suppressed? Do lipolysis-deficient brown 
adipocytes release any “batokines” that are essential for sustaining the whole-
body thermogenic capacity? How does adipose lipolysis deficiency affect cardiac 
health? Are ANP and BNP derived from the heart involved in the browning of 
WAT deficient in lipolysis? Future studies addressing these questions are 
warranted.          
 
 



























































Figure 16. A Proposed Model of Thermoregulation in Mice Deficient in CGI-
58 in Brown and/or White Adipocytes. 
CGI-58-ablated brown adipocytes enhance their uptake of thermogenic 
substrates from the blood circulation. These substrates include glucose derived 
from diet and gluconeogenesis as well as FFAs derived from WAT lipolysis and 
intravascular lipolysis of dietary fat. Deficiency of CGI-58 in brown adipocytes 
also induces WAT browning. As a result, mice deficient in BAT lipolysis are able 
to tolerate cold in both fed and fasted states. When CGI-58 is deficient in both 
brown and white adipocytes, mice cannot tolerate cold during fasting, but they 
can tolerate cold when food is present. In addition, adipose lipolysis deficiency 
increases cardiac uptake of glucose, resulting in cardiac remodeling and 
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increased expression of ANP and BNP, two cardiac hormones that have been 
implicated in promotion of WAT browning. 
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